Pharmaceutical Quality Control Market By Application (Allergens, antigens, vaccines & hormones, Cytokines, enzymes & human whole-blood, Plasma derivative, Immune sera, immunoglobulins & products of fermentation and Others (diagnostic agents for in vitro use, etc.)); By Offering (Consumables & Instruments, Solutions, & Services); By Techniques (GC/MS, LC/MS/ High Performance Liquid (HPLC), Ultra High Performance Liquid (UHPLC), Supercritical Fluid (SFC) chromatography, Elemental analysis techniques, & Others)); By Testing Categories (Elemental Impurities, Volatile Organic Impurities, Extractables & Leachables, Semi-Volatile Organic Impurities, Non-Volatile Organic Impurities, Counterion Analysis, & Others); By Analysis Type (Pharmaceutical Microbiology (Sterility Testing, Antimicrobial Efficacy Testing (AET), Microbial Limits Testing, Bioburden Determination, Endotoxin Testing, Environmental Monitoring & Identification, Packaging Testing, Pharmaceutical & Biopharmaceutical Release Testing, Pharmaceutical Gas Testing, Viral Safety Testing and Lot Release Testing and Others (Water Analysis etc.) and Pharmaceutical Chemistry (Elemental Impurities, Volatile Organic Impurities, Extractables & Leachables, Semi-Volatile Organic Impurities, Non-Volatile Organic Impurities, Counterion Analysis, & Others)); By Region (North America (U.S., Canada, Mexico, & Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden & Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), & Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore & Rest of Southeast Asia), & Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, & Rest of Middle East & Africa) Latin America (Brazil, Argentina, & Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029

Report ID :AMI-875 | Category : Healthcare | Published Date : August, 2021 | Pages : 402 | Format :PDF

Industry Trends

In the global pharmaceutical quality control market, the major drivers contributing to the market growth are focus on the efficiency of pharmaceutical medicines, availability of better storage facilities, regulatory changes to simplify the process of obtaining permits related to medicine manufacturing and quality control for the same, and new therapeutic applications that aid the production of new medicines amongst others.

Concerns regarding supply chain is restraining the growth of global pharmaceutical quality control market. Disruptions in manufacturing processes tend to disrupt the market growth due to logistical issues and regulatory issues.

At every stage of drug development, manufacturers along with pharmaceutical experts explore workflow solutions and scientific choices in order to ensure quality of pharmaceutical drugs. Quality documentation assistance to facilitate accreditation and audits is also necessary for this purpose. From the early stage of drug development, complying with international specifications for quality control and pharmaceutical analysis is important. All these things are integral to pharmaceutical quality control.

Due to the China-originated coronavirus pandemic, global biopharma supply chain felt the need to speed up research to produce a cure. As the commonly used supplies in biopharma manufacturing such as surgical masks, testing swabs, and alcohol-based disinfectants faced increasing demand and depleted inventory due to reduction in production caused by lack of raw materials, many companies sought alternative suppliers so that at least standard operations could be maintained. Owing to the rapid spread of the infectious and chronic diseases, production of pharmaceuticals and biopharmaceuticals have been accelerated and the need for quality control has increased to ensure the effectiveness of medicines and vaccines. The pharmaceutical companies are striving to speed up their operations, supply chains, and manufacturing capabilities, along with investments in research to develop vaccines, which showcases significant growth opportunities for the global pharmaceutical quality control market over the future years.

Technological advancements in pharma quality control laboratories in the form of adoption of digital technology and automation is anticipated to contribute towards the growth of the global pharmaceutical quality control market over the forecast period. The emerging technologies range from internet connectivity to advanced analytics, robotics and automation. They are expected to boost productivity by 30% to 40% within already mature and efficient lab environments. With a new range of improvements, there can be possibility of over 50% reductions in overall quality control costs. By reducing manual errors and variability, digitization and automation can also ensure better quality and compliance, allowing faster as well as effective resolution of problems.   

In terms of revenue, global pharmaceutical quality control market was valued at US$ 3481.94 Mn in 2020 growing at a CAGR of 13.85% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.  

Global Pharmaceutical Quality Control Market Revenue & Forecast, (US$ Million), 2015 – 2029

Pharmaceutical Quality Control Market

Application Outlook:

As per the application, the global pharmaceutical quality control market is segmented into allergens, antigens, vaccines & hormones, cytokines, enzymes & human whole-blood, plasma derivative, immune sera, immunoglobulins & products of fermentation, and others. Allergens, antigens, vaccines and hormones segment accounted for the highest share in the global pharmaceutical quality control market in 2020.

During the forecast period, the plasma derivative segment is anticipated to witness highest growth rate segment. Plasma derivatives are defined as concentrates of specific plasma proteins that are prepared from pools (many donor units) of plasma. Due to high prevalence of life-threatening ailments such as immunodeficiency diseases and hemophilia, pharmaceutical companies are increasingly investing in the production, quality check, and supply of plasma derivative. For instance, in May 2021 Liminal BioSciences entered into an agreement with Kedrion, to divest its plasma collection and plasma-derived therapeutics business.

Offering Outlook:

In the context of offering, the global pharmaceutical quality control market has been primarily segmented into consumables & instruments, solutions, and services. Among these, consumables & instruments accounted for the highest market share in 2020. Consumables are defined as the key materials that are used in support of manufacturing. The term "consumables" can also be used for materials that come in contact with the product during manufacturing that may not become part of the final product. The three categories of consumables are known as direct quality impacting consumables, indirect quality impacting consumables, and non-quality impacting consumables. Instruments are defined as a wide variety of equipment, machinery, and products. Each instrument is important in the unique step in the manufacturing process. In 2021, the use of Lyophilized beads (Lyobeads) technology increased in the pharma and diagnostics sectors. Lyobeads are defined as spheres of customizable lyophilized material. They contain a defined volume of material per unit. Services segment is expected to achieve tremendous growth in the global pharmaceutical quality control market during the forecast period. 

Techniques Outlook:

Based on techniques, the global pharmaceutical quality control market has been segmented into GC/MS, LC/MS/ high performance liquid (HPLC), ultra high performance liquid (UHPLC), supercritical fluid (SFC) chromatography, elemental analysis techniques, and others. GC/MS accounted for the highest market share in the global pharmaceutical quality control market in 2020. During the forecast period (2021 – 2029), supercritical fluid (SFC) chromatography segment is expected to register highest CAGR. The less expensive procedure of SFC over gas chromatography is expected to lead the market growth for SFC chromatography during the forecast period as the former is cost effective. In March 2021, PerkinElmer Inc. acquired ES Industries, based in New Jersey, U.S., adding state-of-the-art columns and chemistries of the latter to its LC consumables portfolio.

Testing Categories Outlook:

Considering the testing categories, the global pharmaceutical quality control market has been segmented into elemental impurities, volatile organic impurities, extractables & leachables, semi-volatile organic impurities, non-volatile organic impurities, counterion analysis, and others.

Extractable & leachable testing segment was the largest market segment in 2020. Extractable analysis identifies the substances that can potentially migrate from metallic, polymeric, or glass material into the patient. Such substances include catalysts, dyes, and plasticizers. Extractables are defined as organic chemical species and inorganic chemical species that can be released from the surfaces of components used in the manufacture and storage of drug products under laboratory conditions, such as accelerated temperature or exaggerated temperature, solvents or surface exposure. The leachable analysis identifies substances that migrate from metallic, polymeric, or glass material into the patient and are typically a subset of those identified in the extractable analysis. This type of analysis is required when there is a risk that harmful substances may have leached into a liquid product, such as eye drops, from its container or packaging.

Analysis Type Outlook:

Based on analysis type, the global pharmaceutical quality control market has been segmented into pharmaceutical microbiology and pharmaceutical chemistry. Pharmaceutical microbiology segment has been further segmented into sterility testing, antimicrobial efficacy testing (AET), microbial limits testing, bioburden determination, endotoxin testing, environmental monitoring & identification, packaging testing, pharmaceutical & biopharmaceutical  release testing, pharmaceutical gas testing, viral safety testing & lot release testing and others (water analysis etc.). Pharmaceutical chemistry segment has been further segmented into elemental impurities, volatile organic impurities, extractables & leachables, semi-volatile organic impurities, non-volatile organic impurities, counterion analysis, and others.

Pharmaceutical microbiology segment accounted for the highest market share in global pharmaceutical quality control market in 2020 and during the forecast period, this segment is expected to witness fastest growth rate. Sterility testing is a good manufacturing practice (GMP) microbiology testing requirement for sterile pharmaceuticals, medical devices, and materials and is essential to ensure that they are safe for use. The most common ways of sterility testing include membrane filtration and direct inoculation. Membrane filtration process is defined as a physical separation method that is characterized by the ability to separate molecules of different sizes and characteristics. This process involves the use of membrane technology to separate biomolecules and particles for the concentration of process fluids. In direct inoculation method, test articles are inoculated directly into tubes or bottles containing an appropriate medium before the articles are incubated for 14 days. With sterility testing being one of their specialties, Precision NanoSystems announced their plans to expand global operations and headquarters in August 2021.

Region Outlook:

Based on the regions, North America accounted for a significant share in the global pharmaceutical quality control market in 2020. However, during the forecast period (2021 – 2029), the Asia Pacific region is expected to witness highest growth rate because a large variation in pharmaceutical spending has been observed in this region in past few years. Governments in Asian countries like China, India, Singapore, South Korea, and Japan are supporting the growth of medical sector and thus, investment is increasing in the pharmaceutical sector with emphasis on quality control. In countries like Singapore, rules about the quality of pharmaceutical medicines are strict. Growing medical sector in Asian countries is also expected to drive the market growth of this region over the period of next eight years. In 2020, the Ministry of Health and Welfare (MOHW) in Taiwan approved 355 applications related to Investigational New Drug (IND). 78% of these applications were about multinational trials. Hence, Taiwan is growing as a regional hub for new drug discovery in the Asia Pacific region and procedures of quality checks and quality control are also rapidly progressing in the country.

Competitive Landscape Outlook:

The report provides both, qualitative as well as quantitative research of global pharmaceutical quality control market. It also provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as affiliations, collaborations, mergers & acquisitions (M&A), and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.

Some of the players operating in the pharmaceutical quality control market are Lucideon Limited, ThermoFisher Scientific, Merck KGaA, Charles River Laboratories, Eurofins Scientific, SGS Group Management SA, Toxikon Corporation, and Sartorius AG, amongst others.

Global Pharmaceutical Quality Control Market:

  • By Application
  • Allergens, antigens, vaccines and hormones
  • Cytokines, enzymes and human whole-blood
  • Plasma derivative
  • Immune sera, immunoglobulins and products of fermentation
  • Others (diagnostic agents for in vitro use, etc.)
  • By Offering
  • Consumables and Instruments
  • Solutions
  • Services
  •  
  • By Techniques
  • GC/MS 
  • LC/MS/ High Performance Liquid (HPLC)
  • Ultra High Performance Liquid (UHPLC)
  • Supercritical Fluid (SFC) chromatography
  • Elemental analysis techniques
  • Others
  • By Testing Categories
  • Elemental Impurities
  • Volatile Organic Impurities
  • Extractables and Leachables
  • Semi-Volatile Organic Impurites
  • Non-Volatile Organic Impurites
  • Counterion Analysis
  • Others
  • By Analysis Type
  • Pharmaceutical Microbiology
  • Sterility Testing
  • Antimicrobial Efficacy Testing (AET)
  • Microbial Limits Testing
  • Bioburden Determination
  • Endotoxin Testing
  • Environmental Monitoring and Identification
  • Packaging Testing
  • Pharmaceutical and Biopharmaceutical Release Testing
  • Pharmaceutical Gas Testing
  • Viral Safety Testing and Lot Release Testing
  • Others (Water Analysis and etc.)
  • Pharmaceutical Chemistry
  • Elemental Impurities
  • Volatile Organic Impurities
  • Extractables and Leachables
  • Semi-Volatile Organic Impurites
  • Non-Volatile Organic Impurites
  • Counterion Analysis
  • Others
  • By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Nordic Countries
  • Denmark
  • Finland
  • Iceland
  • Sweden
  • Norway
  • Benelux Union
  • Belgium
  • The Netherlands
  • Luxembourg
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Southeast Asia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Rest of Southeast Asia
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Brazil
  • Argentina
  • Rest of Latin America


Table of Contents

1.    Market Scope

1.1.   Market Segmentation

1.2.   Years Considered

1.2.1.    Historic Years: 2015 - 2019

1.2.2.    Base Year: 2020

1.2.3.    Forecast Years: 2021 – 2029

2.    Key Target Audiences

3.    Research Methodology

3.1.   Primary Research

3.1.1.    Research Questionnaire

3.1.2.    Global Percentage Breakdown

3.1.3.    Primary Interviews: Key Opinion Leaders (KOLs)

3.2.   Secondary Research

3.2.1.    Paid Databases

3.2.2.    Secondary Sources

3.3.   Market Size Estimates

3.3.1.    Top-Down Approach

3.3.2.    Bottom-Up Approach

3.4.   Data Triangulation Methodology

3.5.   Research Assumptions

4.    Recommendations and Insights from AMI’s Perspective**

5.    Holistic Overview of Pharmaceutical Quality Control Market

6.    Market Synopsis:  Pharmaceutical Quality Control Market

7.    Pharmaceutical Quality Control Market Analysis: Qualitative Perspective

7.1.   Introduction

7.1.1.    Product Definition

7.1.2.    Industry Development

7.2.   Market Dynamics

7.2.1.    Drivers

7.2.2.    Restraints

7.2.3.    Opportunities

7.3.   Trends in Pharmaceutical Quality Control Market

7.4.   Market Determinants Radar Chart

7.5.   Macro-Economic and Micro-Economic Indicators: Pharmaceutical Quality Control Market

7.6.   Porter’s Five Force Analysis

7.7.   Impact of Covid-19 on Pharmaceutical Quality Control Market

8.    Global Pharmaceutical Quality Control Market Analysis and Forecasts, 2021 – 2029

8.1.   Overview

8.1.1.    Global Pharmaceutical Quality Control Market Revenue (US$ Mn)

8.2.   Global Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

8.2.1.    Allergens, antigens, vaccines and hormones

8.2.1.1.    Definition

8.2.1.2.    Market Estimation and Penetration, 2015 - 2020

8.2.1.3.    Market Forecast, 2021 - 2029

8.2.1.4.    Compound Annual Growth Rate (CAGR)

8.2.1.5.    Regional Bifurcation

8.2.1.5.1.    North America

8.2.1.5.1.1. Market Estimation, 2015 - 2020

8.2.1.5.1.2. Market Forecast, 2021 - 2029

8.2.1.5.2.    Europe

8.2.1.5.2.1. Market Estimation, 2015 - 2020

8.2.1.5.2.2. Market Forecast, 2021 - 2029

8.2.1.5.3.    Asia Pacific

8.2.1.5.3.1. Market Estimation, 2015 - 2020

8.2.1.5.3.2. Market Forecast, 2021 - 2029

8.2.1.5.4.    Middle East and Africa

8.2.1.5.4.1. Market Estimation, 2015 - 2020

8.2.1.5.4.2. Market Forecast, 2021 - 2029

8.2.1.5.5.    Latin America

8.2.1.5.5.1. Market Estimation, 2015 - 2020

8.2.1.5.5.2. Market Forecast, 2021 - 2029

8.2.2.    Cytokines, enzymes and human whole-blood

8.2.2.1.    Definition

8.2.2.2.    Market Estimation and Penetration, 2015 - 2020

8.2.2.3.    Market Forecast, 2021 - 2029

8.2.2.4.    Compound Annual Growth Rate (CAGR)

8.2.2.5.    Regional Bifurcation

8.2.2.5.1.    North America

8.2.2.5.1.1. Market Estimation, 2015 - 2020

8.2.2.5.1.2. Market Forecast, 2021 - 2029

8.2.2.5.2.    Europe

8.2.2.5.2.1. Market Estimation, 2015 - 2020

8.2.2.5.2.2. Market Forecast, 2021 - 2029

8.2.2.5.3.    Asia Pacific

8.2.2.5.3.1. Market Estimation, 2015 - 2020

8.2.2.5.3.2. Market Forecast, 2021 - 2029

8.2.2.5.4.    Middle East and Africa

8.2.2.5.4.1. Market Estimation, 2015 - 2020

8.2.2.5.4.2. Market Forecast, 2021 - 2029

8.2.2.5.5.    Latin America

8.2.2.5.5.1. Market Estimation, 2015 - 2020

8.2.2.5.5.2. Market Forecast, 2021 - 2029

8.2.3.    Plasma derivative

8.2.3.1.    Definition

8.2.3.2.    Market Estimation and Penetration, 2015 - 2020

8.2.3.3.    Market Forecast, 2021 - 2029

8.2.3.4.    Compound Annual Growth Rate (CAGR)

8.2.3.5.    Regional Bifurcation

8.2.3.5.1.    North America

8.2.3.5.1.1. Market Estimation, 2015 - 2020

8.2.3.5.1.2. Market Forecast, 2021 - 2029

8.2.3.5.2.    Europe

8.2.3.5.2.1. Market Estimation, 2015 - 2020

8.2.3.5.2.2. Market Forecast, 2021 - 2029

8.2.3.5.3.    Asia Pacific

8.2.3.5.3.1. Market Estimation, 2015 - 2020

8.2.3.5.3.2. Market Forecast, 2021 - 2029

8.2.3.5.4.    Middle East and Africa

8.2.3.5.4.1. Market Estimation, 2015 - 2020

8.2.3.5.4.2. Market Forecast, 2021 - 2029

8.2.3.5.5.    Latin America

8.2.3.5.5.1. Market Estimation, 2015 - 2020

8.2.3.5.5.2. Market Forecast, 2021 - 2029

8.2.4.    Immune sera, immunoglobulins and products of fermentation

8.2.4.1.    Definition

8.2.4.2.    Market Estimation and Penetration, 2015 - 2020

8.2.4.3.    Market Forecast, 2021 - 2029

8.2.4.4.    Compound Annual Growth Rate (CAGR)

8.2.4.5.    Regional Bifurcation

8.2.4.5.1.    North America

8.2.4.5.1.1. Market Estimation, 2015 - 2020

8.2.4.5.1.2. Market Forecast, 2021 - 2029

8.2.4.5.2.    Europe

8.2.4.5.2.1. Market Estimation, 2015 - 2020

8.2.4.5.2.2. Market Forecast, 2021 - 2029

8.2.4.5.3.    Asia Pacific

8.2.4.5.3.1. Market Estimation, 2015 - 2020

8.2.4.5.3.2. Market Forecast, 2021 - 2029

8.2.4.5.4.    Middle East and Africa

8.2.4.5.4.1. Market Estimation, 2015 - 2020

8.2.4.5.4.2. Market Forecast, 2021 - 2029

8.2.4.5.5.    Latin America

8.2.4.5.5.1. Market Estimation, 2015 - 2020

8.2.4.5.5.2. Market Forecast, 2021 - 2029

8.2.5.    Others (diagnostic agents for in vitro use, etc.)

8.2.5.1.    Definition

8.2.5.2.    Market Estimation and Penetration, 2015 - 2020

8.2.5.3.    Market Forecast, 2021 - 2029

8.2.5.4.    Compound Annual Growth Rate (CAGR)

8.2.5.5.    Regional Bifurcation

8.2.5.5.1.    North America

8.2.5.5.1.1. Market Estimation, 2015 - 2020

8.2.5.5.1.2. Market Forecast, 2021 - 2029

8.2.5.5.2.    Europe

8.2.5.5.2.1. Market Estimation, 2015 - 2020

8.2.5.5.2.2. Market Forecast, 2021 - 2029

8.2.5.5.3.    Asia Pacific

8.2.5.5.3.1. Market Estimation, 2015 - 2020

8.2.5.5.3.2. Market Forecast, 2021 - 2029

8.2.5.5.4.    Middle East and Africa

8.2.5.5.4.1. Market Estimation, 2015 - 2020

8.2.5.5.4.2. Market Forecast, 2021 - 2029

8.2.5.5.5.    Latin America

8.2.5.5.5.1. Market Estimation, 2015 - 2020

8.2.5.5.5.2. Market Forecast, 2021 - 2029

8.3.   Key Segment for Channeling Investments

8.3.1.    By Application

9.    Global Pharmaceutical Quality Control Market Analysis and Forecasts, 2021 – 2029

9.1.   Overview

9.2.   Global Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

9.2.1.    Consumables and Instruments

9.2.1.1.    Definition

9.2.1.2.    Market Estimation and Penetration, 2015 - 2020

9.2.1.3.    Market Forecast, 2021 - 2029

9.2.1.4.    Compound Annual Growth Rate (CAGR)

9.2.1.5.    Regional Bifurcation

9.2.1.5.1.    North America

9.2.1.5.1.1. Market Estimation, 2015 - 2020

9.2.1.5.1.2. Market Forecast, 2021 - 2029

9.2.1.5.2.    Europe

9.2.1.5.2.1. Market Estimation, 2015 - 2020

9.2.1.5.2.2. Market Forecast, 2021 - 2029

9.2.1.5.3.    Asia Pacific

9.2.1.5.3.1. Market Estimation, 2015 - 2020

9.2.1.5.3.2. Market Forecast, 2021 - 2029

9.2.1.5.4.    Middle East and Africa

9.2.1.5.4.1. Market Estimation, 2015 - 2020

9.2.1.5.4.2. Market Forecast, 2021 - 2029

9.2.1.5.5.    Latin America

9.2.1.5.5.1. Market Estimation, 2015 - 2020

9.2.1.5.5.2. Market Forecast, 2021 - 2029

9.2.2.    Solution

9.2.2.1.    Definition

9.2.2.2.    Market Estimation and Penetration, 2015 - 2020

9.2.2.3.    Market Forecast, 2021 - 2029

9.2.2.4.    Compound Annual Growth Rate (CAGR)

9.2.2.5.    Regional Bifurcation

9.2.2.5.1.    North America

9.2.2.5.1.1. Market Estimation, 2015 - 2020

9.2.2.5.1.2. Market Forecast, 2021 - 2029

9.2.2.5.2.    Europe

9.2.2.5.2.1. Market Estimation, 2015 - 2020

9.2.2.5.2.2. Market Forecast, 2021 - 2029

9.2.2.5.3.    Asia Pacific

9.2.2.5.3.1. Market Estimation, 2015 - 2020

9.2.2.5.3.2. Market Forecast, 2021 - 2029

9.2.2.5.4.    Middle East and Africa

9.2.2.5.4.1. Market Estimation, 2015 - 2020

9.2.2.5.4.2. Market Forecast, 2021 - 2029

9.2.2.5.5.    Latin America

9.2.2.5.5.1. Market Estimation, 2015 - 2020

9.2.2.5.5.2. Market Forecast, 2021 - 2029

9.2.3.    Services

9.2.3.1.    Definition

9.2.3.2.    Market Estimation and Penetration, 2015 - 2020

9.2.3.3.    Market Forecast, 2021 - 2029

9.2.3.4.    Compound Annual Growth Rate (CAGR)

9.2.3.5.    Regional Bifurcation

9.2.3.5.1.    North America

9.2.3.5.1.1. Market Estimation, 2015 - 2020

9.2.3.5.1.2. Market Forecast, 2021 - 2029

9.2.3.5.2.    Europe

9.2.3.5.2.1. Market Estimation, 2015 - 2020

9.2.3.5.2.2. Market Forecast, 2021 - 2029

9.2.3.5.3.    Asia Pacific

9.2.3.5.3.1. Market Estimation, 2015 - 2020

9.2.3.5.3.2. Market Forecast, 2021 - 2029

9.2.3.5.4.    Middle East and Africa

9.2.3.5.4.1. Market Estimation, 2015 - 2020

9.2.3.5.4.2. Market Forecast, 2021 - 2029

9.2.3.5.5.    Latin America

9.2.3.5.5.1. Market Estimation, 2015 - 2020

9.2.3.5.5.2. Market Forecast, 2021 - 2029

9.3.   Key Segment for Channeling Investments

9.3.1.    By Offering

10. Global Pharmaceutical Quality Control Market Analysis and Forecasts, 2021 – 2029

10.1. Overview

10.2. Global Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

10.2.1. GC/MS

10.2.1.1. Definition

10.2.1.2. Market Estimation and Penetration, 2015 - 2020

10.2.1.3. Market Forecast, 2021 - 2029

10.2.1.4. Compound Annual Growth Rate (CAGR)

10.2.1.5. Regional Bifurcation

10.2.1.5.1. North America

10.2.1.5.1.1. Market Estimation, 2015 - 2020

10.2.1.5.1.2. Market Forecast, 2021 - 2029

10.2.1.5.2. Europe

10.2.1.5.2.1. Market Estimation, 2015 - 2020

10.2.1.5.2.2. Market Forecast, 2021 - 2029

10.2.1.5.3. Asia Pacific

10.2.1.5.3.1. Market Estimation, 2015 - 2020

10.2.1.5.3.2. Market Forecast, 2021 - 2029

10.2.1.5.4. Middle East and Africa

10.2.1.5.4.1. Market Estimation, 2015 - 2020

10.2.1.5.4.2. Market Forecast, 2021 - 2029

10.2.1.5.5. Latin America

10.2.1.5.5.1. Market Estimation, 2015 - 2020

10.2.1.5.5.2. Market Forecast, 2021 - 2029

10.2.2.  LC/MS/ High Performance Liquid (HPLC)

10.2.2.1. Definition

10.2.2.2. Market Estimation and Penetration, 2015 - 2020

10.2.2.3. Market Forecast, 2021 - 2029

10.2.2.4. Compound Annual Growth Rate (CAGR)

10.2.2.5. Regional Bifurcation

10.2.2.5.1. North America

10.2.2.5.1.1. Market Estimation, 2015 - 2020

10.2.2.5.1.2. Market Forecast, 2021 - 2029

10.2.2.5.2. Europe

10.2.2.5.2.1. Market Estimation, 2015 - 2020

10.2.2.5.2.2. Market Forecast, 2021 - 2029

10.2.2.5.3. Asia Pacific

10.2.2.5.3.1. Market Estimation, 2015 - 2020

10.2.2.5.3.2. Market Forecast, 2021 - 2029

10.2.2.5.4. Middle East and Africa

10.2.2.5.4.1. Market Estimation, 2015 - 2020

10.2.2.5.4.2. Market Forecast, 2021 - 2029

10.2.2.5.5. Latin America

10.2.2.5.5.1. Market Estimation, 2015 - 2020

10.2.2.5.5.2. Market Forecast, 2021 - 2029

10.2.3. Ultra High Performance Liquid (UHPLC)

10.2.3.1. Definition

10.2.3.2. Market Estimation and Penetration, 2015 - 2020

10.2.3.3. Market Forecast, 2021 - 2029

10.2.3.4. Compound Annual Growth Rate (CAGR)

10.2.3.5. Regional Bifurcation

10.2.3.5.1. North America

10.2.3.5.1.1. Market Estimation, 2015 - 2020

10.2.3.5.1.2. Market Forecast, 2021 - 2029

10.2.3.5.2. Europe

10.2.3.5.2.1. Market Estimation, 2015 - 2020

10.2.3.5.2.2. Market Forecast, 2021 - 2029

10.2.3.5.3. Asia Pacific

10.2.3.5.3.1. Market Estimation, 2015 - 2020

10.2.3.5.3.2. Market Forecast, 2021 - 2029

10.2.3.5.4. Middle East and Africa

10.2.3.5.4.1. Market Estimation, 2015 - 2020

10.2.3.5.4.2. Market Forecast, 2021 - 2029

10.2.3.5.5. Latin America

10.2.3.5.5.1. Market Estimation, 2015 - 2020

10.2.3.5.5.2. Market Forecast, 2021 - 2029

10.2.4. Supercritical Fluid (SFC) chromatography

10.2.4.1. Definition

10.2.4.2. Market Estimation and Penetration, 2015 - 2020

10.2.4.3. Market Forecast, 2021 - 2029

10.2.4.4. Compound Annual Growth Rate (CAGR)

10.2.4.5. Regional Bifurcation

10.2.4.5.1. North America

10.2.4.5.1.1. Market Estimation, 2015 - 2020

10.2.4.5.1.2. Market Forecast, 2021 - 2029

10.2.4.5.2. Europe

10.2.4.5.2.1. Market Estimation, 2015 - 2020

10.2.4.5.2.2. Market Forecast, 2021 - 2029

10.2.4.5.3. Asia Pacific

10.2.4.5.3.1. Market Estimation, 2015 - 2020

10.2.4.5.3.2. Market Forecast, 2021 - 2029

10.2.4.5.4. Middle East and Africa

10.2.4.5.4.1. Market Estimation, 2015 - 2020

10.2.4.5.4.2. Market Forecast, 2021 - 2029

10.2.4.5.5. Latin America

10.2.4.5.5.1. Market Estimation, 2015 - 2020

10.2.4.5.5.2. Market Forecast, 2021 - 2029

10.2.5. Elemental analysis techniques

10.2.5.1. Definition

10.2.5.2. Market Estimation and Penetration, 2015 - 2020

10.2.5.3. Market Forecast, 2021 - 2029

10.2.5.4. Compound Annual Growth Rate (CAGR)

10.2.5.5. Regional Bifurcation

10.2.5.5.1. North America

10.2.5.5.1.1. Market Estimation, 2015 - 2020

10.2.5.5.1.2. Market Forecast, 2021 - 2029

10.2.5.5.2. Europe

10.2.5.5.2.1. Market Estimation, 2015 - 2020

10.2.5.5.2.2. Market Forecast, 2021 - 2029

10.2.5.5.3. Asia Pacific

10.2.5.5.3.1. Market Estimation, 2015 - 2020

10.2.5.5.3.2. Market Forecast, 2021 - 2029

10.2.5.5.4. Middle East and Africa

10.2.5.5.4.1. Market Estimation, 2015 - 2020

10.2.5.5.4.2. Market Forecast, 2021 - 2029

10.2.5.5.5. Latin America

10.2.5.5.5.1. Market Estimation, 2015 - 2020

10.2.5.5.5.2. Market Forecast, 2021 - 2029

10.2.6. Others

10.2.6.1. Definition

10.2.6.2. Market Estimation and Penetration, 2015 - 2020

10.2.6.3. Market Forecast, 2021 - 2029

10.2.6.4. Compound Annual Growth Rate (CAGR)

10.2.6.5. Regional Bifurcation

10.2.6.5.1. North America

10.2.6.5.1.1. Market Estimation, 2015 - 2020

10.2.6.5.1.2. Market Forecast, 2021 - 2029

10.2.6.5.2. Europe

10.2.6.5.2.1. Market Estimation, 2015 - 2020

10.2.6.5.2.2. Market Forecast, 2021 - 2029

10.2.6.5.3. Asia Pacific

10.2.6.5.3.1. Market Estimation, 2015 - 2020

10.2.6.5.3.2. Market Forecast, 2021 - 2029

10.2.6.5.4. Middle East and Africa

10.2.6.5.4.1. Market Estimation, 2015 - 2020

10.2.6.5.4.2. Market Forecast, 2021 - 2029

10.2.6.5.5. Latin America

10.2.6.5.5.1. Market Estimation, 2015 - 2020

10.2.6.5.5.2. Market Forecast, 2021 - 2029

10.3. Key Segment for Channeling Investments

10.3.1. By  Techniques

11. Global Pharmaceutical Quality Control Market Analysis and Forecasts, 2021 – 2029

11.1. Overview

11.2. Global Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

11.2.1. Elemental Impurities

11.2.1.1. Definition

11.2.1.2. Market Estimation and Penetration, 2015 - 2020

11.2.1.3. Market Forecast, 2021 - 2029

11.2.1.4. Compound Annual Growth Rate (CAGR)

11.2.1.5. Regional Bifurcation

11.2.1.5.1. North America

11.2.1.5.1.1. Market Estimation, 2015 - 2020

11.2.1.5.1.2. Market Forecast, 2021 - 2029

11.2.1.5.2. Europe

11.2.1.5.2.1. Market Estimation, 2015 - 2020

11.2.1.5.2.2. Market Forecast, 2021 - 2029

11.2.1.5.3. Asia Pacific

11.2.1.5.3.1. Market Estimation, 2015 - 2020

11.2.1.5.3.2. Market Forecast, 2021 - 2029

11.2.1.5.4. Middle East and Africa

11.2.1.5.4.1. Market Estimation, 2015 - 2020

11.2.1.5.4.2. Market Forecast, 2021 - 2029

11.2.1.5.5. Latin America

11.2.1.5.5.1. Market Estimation, 2015 - 2020

11.2.1.5.5.2. Market Forecast, 2021 - 2029

11.2.2. Volatile Organic Impurities

11.2.2.1. Definition

11.2.2.2. Market Estimation and Penetration, 2015 - 2020

11.2.2.3. Market Forecast, 2021 - 2029

11.2.2.4. Compound Annual Growth Rate (CAGR)

11.2.2.5. Regional Bifurcation

11.2.2.5.1. North America

11.2.2.5.1.1. Market Estimation, 2015 - 2020

11.2.2.5.1.2. Market Forecast, 2021 - 2029

11.2.2.5.2. Europe

11.2.2.5.2.1. Market Estimation, 2015 - 2020

11.2.2.5.2.2. Market Forecast, 2021 - 2029

11.2.2.5.3. Asia Pacific

11.2.2.5.3.1. Market Estimation, 2015 - 2020

11.2.2.5.3.2. Market Forecast, 2021 - 2029

11.2.2.5.4. Middle East and Africa

11.2.2.5.4.1. Market Estimation, 2015 - 2020

11.2.2.5.4.2. Market Forecast, 2021 - 2029

11.2.2.5.5. Latin America

11.2.2.5.5.1. Market Estimation, 2015 - 2020

11.2.2.5.5.2. Market Forecast, 2021 - 2029

11.2.3. Extractables and Leachables

11.2.3.1. Definition

11.2.3.2. Market Estimation and Penetration, 2015 - 2020

11.2.3.3. Market Forecast, 2021 - 2029

11.2.3.4. Compound Annual Growth Rate (CAGR)

11.2.3.5. Regional Bifurcation

11.2.3.5.1. North America

11.2.3.5.1.1. Market Estimation, 2015 - 2020

11.2.3.5.1.2. Market Forecast, 2021 - 2029

11.2.3.5.2. Europe

11.2.3.5.2.1. Market Estimation, 2015 - 2020

11.2.3.5.2.2. Market Forecast, 2021 - 2029

11.2.3.5.3. Asia Pacific

11.2.3.5.3.1. Market Estimation, 2015 - 2020

11.2.3.5.3.2. Market Forecast, 2021 - 2029

11.2.3.5.4. Middle East and Africa

11.2.3.5.4.1. Market Estimation, 2015 - 2020

11.2.3.5.4.2. Market Forecast, 2021 - 2029

11.2.3.5.5. Latin America

11.2.3.5.5.1. Market Estimation, 2015 - 2020

11.2.3.5.5.2. Market Forecast, 2021 - 2029

11.2.4. Semi-Volatile Organic Impurites

11.2.4.1. Definition

11.2.4.2. Market Estimation and Penetration, 2015 - 2020

11.2.4.3. Market Forecast, 2021 - 2029

11.2.4.4. Compound Annual Growth Rate (CAGR)

11.2.4.5. Regional Bifurcation

11.2.4.5.1. North America

11.2.4.5.1.1. Market Estimation, 2015 - 2020

11.2.4.5.1.2. Market Forecast, 2021 - 2029

11.2.4.5.2. Europe

11.2.4.5.2.1. Market Estimation, 2015 - 2020

11.2.4.5.2.2. Market Forecast, 2021 - 2029

11.2.4.5.3. Asia Pacific

11.2.4.5.3.1. Market Estimation, 2015 - 2020

11.2.4.5.3.2. Market Forecast, 2021 - 2029

11.2.4.5.4. Middle East and Africa

11.2.4.5.4.1. Market Estimation, 2015 - 2020

11.2.4.5.4.2. Market Forecast, 2021 - 2029

11.2.4.5.5. Latin America

11.2.4.5.5.1. Market Estimation, 2015 - 2020

11.2.4.5.5.2. Market Forecast, 2021 - 2029

11.2.5. Non-Volatile Organic Impurites

11.2.5.1. Definition

11.2.5.2. Market Estimation and Penetration, 2015 - 2020

11.2.5.3. Market Forecast, 2021 - 2029

11.2.5.4. Compound Annual Growth Rate (CAGR)

11.2.5.5. Regional Bifurcation

11.2.5.5.1. North America

11.2.5.5.1.1. Market Estimation, 2015 - 2020

11.2.5.5.1.2. Market Forecast, 2021 - 2029

11.2.5.5.2. Europe

11.2.5.5.2.1. Market Estimation, 2015 - 2020

11.2.5.5.2.2. Market Forecast, 2021 - 2029

11.2.5.5.3. Asia Pacific

11.2.5.5.3.1. Market Estimation, 2015 - 2020

11.2.5.5.3.2. Market Forecast, 2021 - 2029

11.2.5.5.4. Middle East and Africa

11.2.5.5.4.1. Market Estimation, 2015 - 2020

11.2.5.5.4.2. Market Forecast, 2021 - 2029

11.2.5.5.5. Latin America

11.2.5.5.5.1. Market Estimation, 2015 - 2020

11.2.5.5.5.2. Market Forecast, 2021 - 2029

11.2.6. Counterion Analysis

11.2.6.1. Definition

11.2.6.2. Market Estimation and Penetration, 2015 - 2020

11.2.6.3. Market Forecast, 2021 - 2029

11.2.6.4. Compound Annual Growth Rate (CAGR)

11.2.6.5. Regional Bifurcation

11.2.6.5.1. North America

11.2.6.5.1.1. Market Estimation, 2015 - 2020

11.2.6.5.1.2. Market Forecast, 2021 - 2029

11.2.6.5.2. Europe

11.2.6.5.2.1. Market Estimation, 2015 - 2020

11.2.6.5.2.2. Market Forecast, 2021 - 2029

11.2.6.5.3. Asia Pacific

11.2.6.5.3.1. Market Estimation, 2015 - 2020

11.2.6.5.3.2. Market Forecast, 2021 - 2029

11.2.6.5.4. Middle East and Africa

11.2.6.5.4.1. Market Estimation, 2015 - 2020

11.2.6.5.4.2. Market Forecast, 2021 - 2029

11.2.6.5.5. Latin America

11.2.6.5.5.1. Market Estimation, 2015 - 2020

11.2.6.5.5.2. Market Forecast, 2021 - 2029

11.2.7. Others

11.2.7.1. Definition

11.2.7.2. Market Estimation and Penetration, 2015 - 2020

11.2.7.3. Market Forecast, 2021 - 2029

11.2.7.4. Compound Annual Growth Rate (CAGR)

11.2.7.5. Regional Bifurcation

11.2.7.5.1. North America

11.2.7.5.1.1. Market Estimation, 2015 - 2020

11.2.7.5.1.2. Market Forecast, 2021 - 2029

11.2.7.5.2. Europe

11.2.7.5.2.1. Market Estimation, 2015 - 2020

11.2.7.5.2.2. Market Forecast, 2021 - 2029

11.2.7.5.3. Asia Pacific

11.2.7.5.3.1. Market Estimation, 2015 - 2020

11.2.7.5.3.2. Market Forecast, 2021 - 2029

11.2.7.5.4. Middle East and Africa

11.2.7.5.4.1. Market Estimation, 2015 - 2020

11.2.7.5.4.2. Market Forecast, 2021 - 2029

11.2.7.5.5. Latin America

11.2.7.5.5.1. Market Estimation, 2015 - 2020

11.2.7.5.5.2. Market Forecast, 2021 - 2029

11.3. Key Segment for Channeling Investments

11.3.1. By Testing Categories

12. Global Pharmaceutical Quality Control Market Analysis and Forecasts, 2021 – 2029

12.1. Overview

12.2. Global Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

12.2.1. Pharmaceutical Microbiology (Definition, Market Estimation and Penetration, 2015 - 2020, Market Estimation (2015 - 2020), Market Forecast (2021 - 2029), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Sterility Testing, Antimicrobial Efficacy Testing (AET), Microbial Limits Testing, Bioburden Determination, Endotoxin Testing, Environmental Monitoring and Identification, Packaging Testing, Pharmaceutical and Biopharmaceutical  Release Testing, Pharmaceutical Gas Testing, Viral Safety Testing and Lot Release Testing, Others (Water Analysis and etc.))

12.2.1.1. Sterility Testing

12.2.1.2. Antimicrobial Efficacy Testing (AET)

12.2.1.3. Microbial Limits Testing

12.2.1.4. Bioburden Determination

12.2.1.5. Endotoxin Testing

12.2.1.6. Environmental Monitoring and Identification

12.2.1.7. Packaging Testing

12.2.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

12.2.1.9. Pharmaceutical Gas Testing

12.2.1.10.             Viral Safety Testing and Lot Release Testing

12.2.1.11.             Others (Water Analysis and etc.)

12.2.2. Pharmaceutical Chemistry (Definition, Market Estimation and Penetration, 2015 - 2020, Market Estimation (2015 - 2020), Market Forecast (2021 - 2029), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Elemental Impurities, Volatile Organic Impurities, Extractables and Leachables , Semi-Volatile Organic Impurites, Non-Volatile Organic Impurites, Counterion Analysis , Others)

12.2.2.1. Elemental Impurities

12.2.2.2. Volatile Organic Impurities

12.2.2.3. Extractables and Leachables

12.2.2.4. Semi-Volatile Organic Impurites

12.2.2.5. Non-Volatile Organic Impurites

12.2.2.6. Counterion Analysis

12.2.2.7. Others

12.3. Key Segment for Channeling Investments

12.3.1. By Analysis Type

13. North America Pharmaceutical Quality Control Market Analysis and Forecasts, 2021 - 2029

13.1. Overview

13.1.1. North America Pharmaceutical Quality Control Market Revenue (US$ Mn)

13.2. North America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

13.2.1. Allergens, antigens, vaccines and hormones

13.2.2. Cytokines, enzymes and human whole-blood

13.2.3. Plasma derivative

13.2.4. Immune sera, immunoglobulins and products of fermentation

13.2.5. Others (diagnostic agents for in vitro use, etc.)

13.3. North America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

13.3.1. Consumables and Instruments

13.3.2. Solution

13.3.3. Services

13.4. North America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

13.4.1. GC/MS

13.4.2.  LC/MS/ High Performance Liquid (HPLC)

13.4.3. Ultra High Performance Liquid (UHPLC)

13.4.4. Supercritical Fluid (SFC) chromatography

13.4.5. Elemental analysis techniques

13.4.6. Others

13.5. North America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

13.5.1. Elemental Impurities

13.5.2. Volatile Organic Impurities

13.5.3. Extractables and Leachables

13.5.4. Semi-Volatile Organic Impurites

13.5.5. Non-Volatile Organic Impurites

13.5.6. Counterion Analysis

13.5.7. Others

13.6. North America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

13.6.1. Pharmaceutical Microbiology

13.6.1.1. Sterility Testing

13.6.1.2. Antimicrobial Efficacy Testing (AET)

13.6.1.3. Microbial Limits Testing

13.6.1.4. Bioburden Determination

13.6.1.5. Endotoxin Testing

13.6.1.6. Environmental Monitoring and Identification

13.6.1.7. Packaging Testing

13.6.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

13.6.1.9. Pharmaceutical Gas Testing

13.6.1.10.             Viral Safety Testing and Lot Release Testing

13.6.1.11.             Others (Water Analysis and etc.)

13.6.2. Pharmaceutical Chemistry

13.6.2.1. Elemental Impurities

13.6.2.2. Volatile Organic Impurities

13.6.2.3. Extractables and Leachables

13.6.2.4. Semi-Volatile Organic Impurites

13.6.2.5. Non-Volatile Organic Impurites

13.6.2.6. Counterion Analysis

13.6.2.7. Others

13.7. North America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Country

13.7.1. U.S

13.7.1.1. U.S Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

13.7.1.1.1. Allergens, antigens, vaccines and hormones

13.7.1.1.2. Cytokines, enzymes and human whole-blood

13.7.1.1.3. Plasma derivative

13.7.1.1.4. Immune sera, immunoglobulins and products of fermentation

13.7.1.1.5. Others (diagnostic agents for in vitro use, etc.)

13.7.1.2. U.S Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

13.7.1.2.1. Consumables and Instruments

13.7.1.2.2. Solution

13.7.1.2.3. Services

13.7.1.3. U.S Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

13.7.1.3.1. GC/MS

13.7.1.3.2.  LC/MS/ High Performance Liquid (HPLC)

13.7.1.3.3. Ultra High Performance Liquid (UHPLC)

13.7.1.3.4. Supercritical Fluid (SFC) chromatography

13.7.1.3.5. Elemental analysis techniques

13.7.1.3.6. Others

13.7.1.4. U.S Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

13.7.1.4.1. Elemental Impurities

13.7.1.4.2. Volatile Organic Impurities

13.7.1.4.3. Extractables and Leachables

13.7.1.4.4. Semi-Volatile Organic Impurites

13.7.1.4.5. Non-Volatile Organic Impurites

13.7.1.4.6. Counterion Analysis

13.7.1.4.7. Others

13.7.1.5. U.S Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

13.7.1.5.1. Pharmaceutical Microbiology

13.7.1.5.1.1. Sterility Testing

13.7.1.5.1.2. Antimicrobial Efficacy Testing (AET)

13.7.1.5.1.3. Microbial Limits Testing

13.7.1.5.1.4. Bioburden Determination

13.7.1.5.1.5. Endotoxin Testing

13.7.1.5.1.6. Environmental Monitoring and Identification

13.7.1.5.1.7. Packaging Testing

13.7.1.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

13.7.1.5.1.9. Pharmaceutical Gas Testing

13.7.1.5.1.10. Viral Safety Testing and Lot Release Testing

13.7.1.5.1.11. Others (Water Analysis and etc.)

13.7.1.5.2. Pharmaceutical Chemistry

13.7.1.5.2.1. Elemental Impurities

13.7.1.5.2.2. Volatile Organic Impurities

13.7.1.5.2.3. Extractables and Leachables

13.7.1.5.2.4. Semi-Volatile Organic Impurites

13.7.1.5.2.5. Non-Volatile Organic Impurites

13.7.1.5.2.6. Counterion Analysis

13.7.1.5.2.7. Others

13.7.2. Canada

13.7.2.1. Canada Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

13.7.2.1.1. Allergens, antigens, vaccines and hormones

13.7.2.1.2. Cytokines, enzymes and human whole-blood

13.7.2.1.3. Plasma derivative

13.7.2.1.4. Immune sera, immunoglobulins and products of fermentation

13.7.2.1.5. Others (diagnostic agents for in vitro use, etc.)

13.7.2.2. Canada Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

13.7.2.2.1. Consumables and Instruments

13.7.2.2.2. Solution

13.7.2.2.3. Services

13.7.2.3. Canada Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

13.7.2.3.1. GC/MS

13.7.2.3.2.  LC/MS/ High Performance Liquid (HPLC)

13.7.2.3.3. Ultra High Performance Liquid (UHPLC)

13.7.2.3.4. Supercritical Fluid (SFC) chromatography

13.7.2.3.5. Elemental analysis techniques

13.7.2.3.6. Others

13.7.2.4. Canada Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

13.7.2.4.1. Elemental Impurities

13.7.2.4.2. Volatile Organic Impurities

13.7.2.4.3. Extractables and Leachables

13.7.2.4.4. Semi-Volatile Organic Impurites

13.7.2.4.5. Non-Volatile Organic Impurites

13.7.2.4.6. Counterion Analysis

13.7.2.4.7. Others

13.7.2.5. Canada Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

13.7.2.5.1. Pharmaceutical Microbiology

13.7.2.5.1.1. Sterility Testing

13.7.2.5.1.2. Antimicrobial Efficacy Testing (AET)

13.7.2.5.1.3. Microbial Limits Testing

13.7.2.5.1.4. Bioburden Determination

13.7.2.5.1.5. Endotoxin Testing

13.7.2.5.1.6. Environmental Monitoring and Identification

13.7.2.5.1.7. Packaging Testing

13.7.2.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

13.7.2.5.1.9. Pharmaceutical Gas Testing

13.7.2.5.1.10. Viral Safety Testing and Lot Release Testing

13.7.2.5.1.11. Others (Water Analysis and etc.)

13.7.2.5.2. Pharmaceutical Chemistry

13.7.2.5.2.1. Elemental Impurities

13.7.2.5.2.2. Volatile Organic Impurities

13.7.2.5.2.3. Extractables and Leachables

13.7.2.5.2.4. Semi-Volatile Organic Impurites

13.7.2.5.2.5. Non-Volatile Organic Impurites

13.7.2.5.2.6. Counterion Analysis

13.7.2.5.2.7. Others

13.7.3. Mexico

13.7.3.1. Mexico Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

13.7.3.1.1. Allergens, antigens, vaccines and hormones

13.7.3.1.2. Cytokines, enzymes and human whole-blood

13.7.3.1.3. Plasma derivative

13.7.3.1.4. Immune sera, immunoglobulins and products of fermentation

13.7.3.1.5. Others (diagnostic agents for in vitro use, etc.)

13.7.3.2. Mexico Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

13.7.3.2.1. Consumables and Instruments

13.7.3.2.2. Solution

13.7.3.2.3. Services

13.7.3.3. Mexico Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

13.7.3.3.1. GC/MS

13.7.3.3.2.  LC/MS/ High Performance Liquid (HPLC)

13.7.3.3.3. Ultra High Performance Liquid (UHPLC)

13.7.3.3.4. Supercritical Fluid (SFC) chromatography

13.7.3.3.5. Elemental analysis techniques

13.7.3.3.6. Others

13.7.3.4. Mexico Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

13.7.3.4.1. Elemental Impurities

13.7.3.4.2. Volatile Organic Impurities

13.7.3.4.3. Extractables and Leachables

13.7.3.4.4. Semi-Volatile Organic Impurites

13.7.3.4.5. Non-Volatile Organic Impurites

13.7.3.4.6. Counterion Analysis

13.7.3.4.7. Others

13.7.3.5. Mexico Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

13.7.3.5.1. Pharmaceutical Microbiology

13.7.3.5.1.1. Sterility Testing

13.7.3.5.1.2. Antimicrobial Efficacy Testing (AET)

13.7.3.5.1.3. Microbial Limits Testing

13.7.3.5.1.4. Bioburden Determination

13.7.3.5.1.5. Endotoxin Testing

13.7.3.5.1.6. Environmental Monitoring and Identification

13.7.3.5.1.7. Packaging Testing

13.7.3.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

13.7.3.5.1.9. Pharmaceutical Gas Testing

13.7.3.5.1.10. Viral Safety Testing and Lot Release Testing

13.7.3.5.1.11. Others (Water Analysis and etc.)

13.7.3.5.2. Pharmaceutical Chemistry

13.7.3.5.2.1. Elemental Impurities

13.7.3.5.2.2. Volatile Organic Impurities

13.7.3.5.2.3. Extractables and Leachables

13.7.3.5.2.4. Semi-Volatile Organic Impurites

13.7.3.5.2.5. Non-Volatile Organic Impurites

13.7.3.5.2.6. Counterion Analysis

13.7.3.5.2.7. Others

13.7.4. Rest of North America

13.7.4.1. Rest of North America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

13.7.4.1.1. Allergens, antigens, vaccines and hormones

13.7.4.1.2. Cytokines, enzymes and human whole-blood

13.7.4.1.3. Plasma derivative

13.7.4.1.4. Immune sera, immunoglobulins and products of fermentation

13.7.4.1.5. Others (diagnostic agents for in vitro use, etc.)

13.7.4.2. Rest of North America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

13.7.4.2.1. Consumables and Instruments

13.7.4.2.2. Solution

13.7.4.2.3. Services

13.7.4.3. Rest of North America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

13.7.4.3.1. GC/MS

13.7.4.3.2.  LC/MS/ High Performance Liquid (HPLC)

13.7.4.3.3. Ultra High Performance Liquid (UHPLC)

13.7.4.3.4. Supercritical Fluid (SFC) chromatography

13.7.4.3.5. Elemental analysis techniques

13.7.4.3.6. Others

13.7.4.4. Rest of North America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

13.7.4.4.1. Elemental Impurities

13.7.4.4.2. Volatile Organic Impurities

13.7.4.4.3. Extractables and Leachables

13.7.4.4.4. Semi-Volatile Organic Impurites

13.7.4.4.5. Non-Volatile Organic Impurites

13.7.4.4.6. Counterion Analysis

13.7.4.4.7. Others

13.7.4.5. Rest of North America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

13.7.4.5.1. Pharmaceutical Microbiology

13.7.4.5.1.1. Sterility Testing

13.7.4.5.1.2. Antimicrobial Efficacy Testing (AET)

13.7.4.5.1.3. Microbial Limits Testing

13.7.4.5.1.4. Bioburden Determination

13.7.4.5.1.5. Endotoxin Testing

13.7.4.5.1.6. Environmental Monitoring and Identification

13.7.4.5.1.7. Packaging Testing

13.7.4.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

13.7.4.5.1.9. Pharmaceutical Gas Testing

13.7.4.5.1.10. Viral Safety Testing and Lot Release Testing

13.7.4.5.1.11. Others (Water Analysis and etc.)

13.7.4.5.2. Pharmaceutical Chemistry

13.7.4.5.2.1. Elemental Impurities

13.7.4.5.2.2. Volatile Organic Impurities

13.7.4.5.2.3. Extractables and Leachables

13.7.4.5.2.4. Semi-Volatile Organic Impurites

13.7.4.5.2.5. Non-Volatile Organic Impurites

13.7.4.5.2.6. Counterion Analysis

13.7.4.5.2.7. Others

13.8. Key Segment for Channeling Investments

13.8.1. By Country

13.8.2. By Application

13.8.3. By Offering

13.8.4. By  Techniques

13.8.5. By Testing Categories

13.8.6. By Analysis Type

14. Europe Pharmaceutical Quality Control Market Analysis and Forecasts, 2021 - 2029

14.1. Overview

14.1.1. Europe Pharmaceutical Quality Control Market Revenue (US$ Mn)

14.2. Europe Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

14.2.1. Allergens, antigens, vaccines and hormones

14.2.2. Cytokines, enzymes and human whole-blood

14.2.3. Plasma derivative

14.2.4. Immune sera, immunoglobulins and products of fermentation

14.2.5. Others (diagnostic agents for in vitro use, etc.)

14.3. Europe Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

14.3.1. Consumables and Instruments

14.3.2. Solution

14.3.3. Services

14.4. Europe Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

14.4.1. GC/MS

14.4.2.  LC/MS/ High Performance Liquid (HPLC)

14.4.3. Ultra High Performance Liquid (UHPLC)

14.4.4. Supercritical Fluid (SFC) chromatography

14.4.5. Elemental analysis techniques

14.4.6. Others

14.5. Europe Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

14.5.1. Elemental Impurities

14.5.2. Volatile Organic Impurities

14.5.3. Extractables and Leachables

14.5.4. Semi-Volatile Organic Impurites

14.5.5. Non-Volatile Organic Impurites

14.5.6. Counterion Analysis

14.5.7. Others

14.6. Europe Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

14.6.1. Pharmaceutical Microbiology

14.6.1.1. Sterility Testing

14.6.1.2. Antimicrobial Efficacy Testing (AET)

14.6.1.3. Microbial Limits Testing

14.6.1.4. Bioburden Determination

14.6.1.5. Endotoxin Testing

14.6.1.6. Environmental Monitoring and Identification

14.6.1.7. Packaging Testing

14.6.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

14.6.1.9. Pharmaceutical Gas Testing

14.6.1.10.             Viral Safety Testing and Lot Release Testing

14.6.1.11.             Others (Water Analysis and etc.)

14.6.2. Pharmaceutical Chemistry

14.6.2.1. Elemental Impurities

14.6.2.2. Volatile Organic Impurities

14.6.2.3. Extractables and Leachables

14.6.2.4. Semi-Volatile Organic Impurites

14.6.2.5. Non-Volatile Organic Impurites

14.6.2.6. Counterion Analysis

14.6.2.7. Others

14.7. Europe Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Country

14.7.1. France

14.7.1.1. France Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

14.7.1.1.1. Allergens, antigens, vaccines and hormones

14.7.1.1.2. Cytokines, enzymes and human whole-blood

14.7.1.1.3. Plasma derivative

14.7.1.1.4. Immune sera, immunoglobulins and products of fermentation

14.7.1.1.5. Others (diagnostic agents for in vitro use, etc.)

14.7.1.2. France Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

14.7.1.2.1. Consumables and Instruments

14.7.1.2.2. Solution

14.7.1.2.3. Services

14.7.1.3. France Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

14.7.1.3.1. GC/MS

14.7.1.3.2.  LC/MS/ High Performance Liquid (HPLC)

14.7.1.3.3. Ultra High Performance Liquid (UHPLC)

14.7.1.3.4. Supercritical Fluid (SFC) chromatography

14.7.1.3.5. Elemental analysis techniques

14.7.1.3.6. Others

14.7.1.4. France Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

14.7.1.4.1. Elemental Impurities

14.7.1.4.2. Volatile Organic Impurities

14.7.1.4.3. Extractables and Leachables

14.7.1.4.4. Semi-Volatile Organic Impurites

14.7.1.4.5. Non-Volatile Organic Impurites

14.7.1.4.6. Counterion Analysis

14.7.1.4.7. Others

14.7.1.5. France Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

14.7.1.5.1. Pharmaceutical Microbiology

14.7.1.5.1.1. Sterility Testing

14.7.1.5.1.2. Antimicrobial Efficacy Testing (AET)

14.7.1.5.1.3. Microbial Limits Testing

14.7.1.5.1.4. Bioburden Determination

14.7.1.5.1.5. Endotoxin Testing

14.7.1.5.1.6. Environmental Monitoring and Identification

14.7.1.5.1.7. Packaging Testing

14.7.1.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

14.7.1.5.1.9. Pharmaceutical Gas Testing

14.7.1.5.1.10. Viral Safety Testing and Lot Release Testing

14.7.1.5.1.11. Others (Water Analysis and etc.)

14.7.1.5.2. Pharmaceutical Chemistry

14.7.1.5.2.1. Elemental Impurities

14.7.1.5.2.2. Volatile Organic Impurities

14.7.1.5.2.3. Extractables and Leachables

14.7.1.5.2.4. Semi-Volatile Organic Impurites

14.7.1.5.2.5. Non-Volatile Organic Impurites

14.7.1.5.2.6. Counterion Analysis

14.7.1.5.2.7. Others

14.7.2. The UK

14.7.2.1. The UK Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

14.7.2.1.1. Allergens, antigens, vaccines and hormones

14.7.2.1.2. Cytokines, enzymes and human whole-blood

14.7.2.1.3. Plasma derivative

14.7.2.1.4. Immune sera, immunoglobulins and products of fermentation

14.7.2.1.5. Others (diagnostic agents for in vitro use, etc.)

14.7.2.2. The UK Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

14.7.2.2.1. Consumables and Instruments

14.7.2.2.2. Solution

14.7.2.2.3. Services

14.7.2.3. The UK Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

14.7.2.3.1. GC/MS

14.7.2.3.2.  LC/MS/ High Performance Liquid (HPLC)

14.7.2.3.3. Ultra High Performance Liquid (UHPLC)

14.7.2.3.4. Supercritical Fluid (SFC) chromatography

14.7.2.3.5. Elemental analysis techniques

14.7.2.3.6. Others

14.7.2.4. The UK Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

14.7.2.4.1. Elemental Impurities

14.7.2.4.2. Volatile Organic Impurities

14.7.2.4.3. Extractables and Leachables

14.7.2.4.4. Semi-Volatile Organic Impurites

14.7.2.4.5. Non-Volatile Organic Impurites

14.7.2.4.6. Counterion Analysis

14.7.2.4.7. Others

14.7.2.5. The UK Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

14.7.2.5.1. Pharmaceutical Microbiology

14.7.2.5.1.1. Sterility Testing

14.7.2.5.1.2. Antimicrobial Efficacy Testing (AET)

14.7.2.5.1.3. Microbial Limits Testing

14.7.2.5.1.4. Bioburden Determination

14.7.2.5.1.5. Endotoxin Testing

14.7.2.5.1.6. Environmental Monitoring and Identification

14.7.2.5.1.7. Packaging Testing

14.7.2.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

14.7.2.5.1.9. Pharmaceutical Gas Testing

14.7.2.5.1.10. Viral Safety Testing and Lot Release Testing

14.7.2.5.1.11. Others (Water Analysis and etc.)

14.7.2.5.2. Pharmaceutical Chemistry

14.7.2.5.2.1. Elemental Impurities

14.7.2.5.2.2. Volatile Organic Impurities

14.7.2.5.2.3. Extractables and Leachables

14.7.2.5.2.4. Semi-Volatile Organic Impurites

14.7.2.5.2.5. Non-Volatile Organic Impurites

14.7.2.5.2.6. Counterion Analysis

14.7.2.5.2.7. Others

14.7.3. Spain

14.7.3.1. Spain Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

14.7.3.1.1. Allergens, antigens, vaccines and hormones

14.7.3.1.2. Cytokines, enzymes and human whole-blood

14.7.3.1.3. Plasma derivative

14.7.3.1.4. Immune sera, immunoglobulins and products of fermentation

14.7.3.1.5. Others (diagnostic agents for in vitro use, etc.)

14.7.3.2. Spain Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

14.7.3.2.1. Consumables and Instruments

14.7.3.2.2. Solution

14.7.3.2.3. Services

14.7.3.3. Spain Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

14.7.3.3.1. GC/MS

14.7.3.3.2.  LC/MS/ High Performance Liquid (HPLC)

14.7.3.3.3. Ultra High Performance Liquid (UHPLC)

14.7.3.3.4. Supercritical Fluid (SFC) chromatography

14.7.3.3.5. Elemental analysis techniques

14.7.3.3.6. Others

14.7.3.4. Spain Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

14.7.3.4.1. Elemental Impurities

14.7.3.4.2. Volatile Organic Impurities

14.7.3.4.3. Extractables and Leachables

14.7.3.4.4. Semi-Volatile Organic Impurites

14.7.3.4.5. Non-Volatile Organic Impurites

14.7.3.4.6. Counterion Analysis

14.7.3.4.7. Others

14.7.3.5. Spain Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

14.7.3.5.1. Pharmaceutical Microbiology

14.7.3.5.1.1. Sterility Testing

14.7.3.5.1.2. Antimicrobial Efficacy Testing (AET)

14.7.3.5.1.3. Microbial Limits Testing

14.7.3.5.1.4. Bioburden Determination

14.7.3.5.1.5. Endotoxin Testing

14.7.3.5.1.6. Environmental Monitoring and Identification

14.7.3.5.1.7. Packaging Testing

14.7.3.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

14.7.3.5.1.9. Pharmaceutical Gas Testing

14.7.3.5.1.10. Viral Safety Testing and Lot Release Testing

14.7.3.5.1.11. Others (Water Analysis and etc.)

14.7.3.5.2. Pharmaceutical Chemistry

14.7.3.5.2.1. Elemental Impurities

14.7.3.5.2.2. Volatile Organic Impurities

14.7.3.5.2.3. Extractables and Leachables

14.7.3.5.2.4. Semi-Volatile Organic Impurites

14.7.3.5.2.5. Non-Volatile Organic Impurites

14.7.3.5.2.6. Counterion Analysis

14.7.3.5.2.7. Others

14.7.4. Germany

14.7.4.1. Germany Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

14.7.4.1.1. Allergens, antigens, vaccines and hormones

14.7.4.1.2. Cytokines, enzymes and human whole-blood

14.7.4.1.3. Plasma derivative

14.7.4.1.4. Immune sera, immunoglobulins and products of fermentation

14.7.4.1.5. Others (diagnostic agents for in vitro use, etc.)

14.7.4.2. Germany Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

14.7.4.2.1. Consumables and Instruments

14.7.4.2.2. Solution

14.7.4.2.3. Services

14.7.4.3. Germany Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

14.7.4.3.1. GC/MS

14.7.4.3.2.  LC/MS/ High Performance Liquid (HPLC)

14.7.4.3.3. Ultra High Performance Liquid (UHPLC)

14.7.4.3.4. Supercritical Fluid (SFC) chromatography

14.7.4.3.5. Elemental analysis techniques

14.7.4.3.6. Others

14.7.4.4. Germany Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

14.7.4.4.1. Elemental Impurities

14.7.4.4.2. Volatile Organic Impurities

14.7.4.4.3. Extractables and Leachables

14.7.4.4.4. Semi-Volatile Organic Impurites

14.7.4.4.5. Non-Volatile Organic Impurites

14.7.4.4.6. Counterion Analysis

14.7.4.4.7. Others

14.7.4.5. Germany Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

14.7.4.5.1. Pharmaceutical Microbiology

14.7.4.5.1.1. Sterility Testing

14.7.4.5.1.2. Antimicrobial Efficacy Testing (AET)

14.7.4.5.1.3. Microbial Limits Testing

14.7.4.5.1.4. Bioburden Determination

14.7.4.5.1.5. Endotoxin Testing

14.7.4.5.1.6. Environmental Monitoring and Identification

14.7.4.5.1.7. Packaging Testing

14.7.4.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

14.7.4.5.1.9. Pharmaceutical Gas Testing

14.7.4.5.1.10. Viral Safety Testing and Lot Release Testing

14.7.4.5.1.11. Others (Water Analysis and etc.)

14.7.4.5.2. Pharmaceutical Chemistry

14.7.4.5.2.1. Elemental Impurities

14.7.4.5.2.2. Volatile Organic Impurities

14.7.4.5.2.3. Extractables and Leachables

14.7.4.5.2.4. Semi-Volatile Organic Impurites

14.7.4.5.2.5. Non-Volatile Organic Impurites

14.7.4.5.2.6. Counterion Analysis

14.7.4.5.2.7. Others

14.7.5. Italy

14.7.5.1. Italy Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

14.7.5.1.1. Allergens, antigens, vaccines and hormones

14.7.5.1.2. Cytokines, enzymes and human whole-blood

14.7.5.1.3. Plasma derivative

14.7.5.1.4. Immune sera, immunoglobulins and products of fermentation

14.7.5.1.5. Others (diagnostic agents for in vitro use, etc.)

14.7.5.2. Italy Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

14.7.5.2.1. Consumables and Instruments

14.7.5.2.2. Solution

14.7.5.2.3. Services

14.7.5.3. Italy Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

14.7.5.3.1. GC/MS

14.7.5.3.2.  LC/MS/ High Performance Liquid (HPLC)

14.7.5.3.3. Ultra High Performance Liquid (UHPLC)

14.7.5.3.4. Supercritical Fluid (SFC) chromatography

14.7.5.3.5. Elemental analysis techniques

14.7.5.3.6. Others

14.7.5.4. Italy Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

14.7.5.4.1. Elemental Impurities

14.7.5.4.2. Volatile Organic Impurities

14.7.5.4.3. Extractables and Leachables

14.7.5.4.4. Semi-Volatile Organic Impurites

14.7.5.4.5. Non-Volatile Organic Impurites

14.7.5.4.6. Counterion Analysis

14.7.5.4.7. Others

14.7.5.5. Italy Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

14.7.5.5.1. Pharmaceutical Microbiology

14.7.5.5.1.1. Sterility Testing

14.7.5.5.1.2. Antimicrobial Efficacy Testing (AET)

14.7.5.5.1.3. Microbial Limits Testing

14.7.5.5.1.4. Bioburden Determination

14.7.5.5.1.5. Endotoxin Testing

14.7.5.5.1.6. Environmental Monitoring and Identification

14.7.5.5.1.7. Packaging Testing

14.7.5.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

14.7.5.5.1.9. Pharmaceutical Gas Testing

14.7.5.5.1.10. Viral Safety Testing and Lot Release Testing

14.7.5.5.1.11. Others (Water Analysis and etc.)

14.7.5.5.2. Pharmaceutical Chemistry

14.7.5.5.2.1. Elemental Impurities

14.7.5.5.2.2. Volatile Organic Impurities

14.7.5.5.2.3. Extractables and Leachables

14.7.5.5.2.4. Semi-Volatile Organic Impurites

14.7.5.5.2.5. Non-Volatile Organic Impurites

14.7.5.5.2.6. Counterion Analysis

14.7.5.5.2.7. Others

14.7.6. Nordic Countries

14.7.6.1. Nordic Countries Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

14.7.6.1.1. Allergens, antigens, vaccines and hormones

14.7.6.1.2. Cytokines, enzymes and human whole-blood

14.7.6.1.3. Plasma derivative

14.7.6.1.4. Immune sera, immunoglobulins and products of fermentation

14.7.6.1.5. Others (diagnostic agents for in vitro use, etc.)

14.7.6.2. Nordic Countries Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

14.7.6.2.1. Consumables and Instruments

14.7.6.2.2. Solution

14.7.6.2.3. Services

14.7.6.3. Nordic Countries Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

14.7.6.3.1. GC/MS

14.7.6.3.2.  LC/MS/ High Performance Liquid (HPLC)

14.7.6.3.3. Ultra High Performance Liquid (UHPLC)

14.7.6.3.4. Supercritical Fluid (SFC) chromatography

14.7.6.3.5. Elemental analysis techniques

14.7.6.3.6. Others

14.7.6.4. Nordic Countries Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

14.7.6.4.1. Elemental Impurities

14.7.6.4.2. Volatile Organic Impurities

14.7.6.4.3. Extractables and Leachables

14.7.6.4.4. Semi-Volatile Organic Impurites

14.7.6.4.5. Non-Volatile Organic Impurites

14.7.6.4.6. Counterion Analysis

14.7.6.4.7. Others

14.7.6.5. Nordic Countries Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

14.7.6.5.1. Pharmaceutical Microbiology

14.7.6.5.1.1. Sterility Testing

14.7.6.5.1.2. Antimicrobial Efficacy Testing (AET)

14.7.6.5.1.3. Microbial Limits Testing

14.7.6.5.1.4. Bioburden Determination

14.7.6.5.1.5. Endotoxin Testing

14.7.6.5.1.6. Environmental Monitoring and Identification

14.7.6.5.1.7. Packaging Testing

14.7.6.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

14.7.6.5.1.9. Pharmaceutical Gas Testing

14.7.6.5.1.10. Viral Safety Testing and Lot Release Testing

14.7.6.5.1.11. Others (Water Analysis and etc.)

14.7.6.5.2. Pharmaceutical Chemistry

14.7.6.5.2.1. Elemental Impurities

14.7.6.5.2.2. Volatile Organic Impurities

14.7.6.5.2.3. Extractables and Leachables

14.7.6.5.2.4. Semi-Volatile Organic Impurites

14.7.6.5.2.5. Non-Volatile Organic Impurites

14.7.6.5.2.6. Counterion Analysis

14.7.6.5.2.7. Others

14.7.6.6. Nordic Countries Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Country

14.7.6.6.1. Denmark

14.7.6.6.2. Finland

14.7.6.6.3. Iceland

14.7.6.6.4. Sweden

14.7.6.6.5. Norway

14.7.7. Benelux Union

14.7.7.1. Benelux Union Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

14.7.7.1.1. Allergens, antigens, vaccines and hormones

14.7.7.1.2. Cytokines, enzymes and human whole-blood

14.7.7.1.3. Plasma derivative

14.7.7.1.4. Immune sera, immunoglobulins and products of fermentation

14.7.7.1.5. Others (diagnostic agents for in vitro use, etc.)

14.7.7.2. Benelux Union Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

14.7.7.2.1. Consumables and Instruments

14.7.7.2.2. Solution

14.7.7.2.3. Services

14.7.7.3. Benelux Union Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

14.7.7.3.1. GC/MS

14.7.7.3.2.  LC/MS/ High Performance Liquid (HPLC)

14.7.7.3.3. Ultra High Performance Liquid (UHPLC)

14.7.7.3.4. Supercritical Fluid (SFC) chromatography

14.7.7.3.5. Elemental analysis techniques

14.7.7.3.6. Others

14.7.7.4. Benelux Union Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

14.7.7.4.1. Elemental Impurities

14.7.7.4.2. Volatile Organic Impurities

14.7.7.4.3. Extractables and Leachables

14.7.7.4.4. Semi-Volatile Organic Impurites

14.7.7.4.5. Non-Volatile Organic Impurites

14.7.7.4.6. Counterion Analysis

14.7.7.4.7. Others

14.7.7.5. Benelux Union Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

14.7.7.5.1. Pharmaceutical Microbiology

14.7.7.5.1.1. Sterility Testing

14.7.7.5.1.2. Antimicrobial Efficacy Testing (AET)

14.7.7.5.1.3. Microbial Limits Testing

14.7.7.5.1.4. Bioburden Determination

14.7.7.5.1.5. Endotoxin Testing

14.7.7.5.1.6. Environmental Monitoring and Identification

14.7.7.5.1.7. Packaging Testing

14.7.7.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

14.7.7.5.1.9. Pharmaceutical Gas Testing

14.7.7.5.1.10. Viral Safety Testing and Lot Release Testing

14.7.7.5.1.11. Others (Water Analysis and etc.)

14.7.7.5.2. Pharmaceutical Chemistry

14.7.7.5.2.1. Elemental Impurities

14.7.7.5.2.2. Volatile Organic Impurities

14.7.7.5.2.3. Extractables and Leachables

14.7.7.5.2.4. Semi-Volatile Organic Impurites

14.7.7.5.2.5. Non-Volatile Organic Impurites

14.7.7.5.2.6. Counterion Analysis

14.7.7.5.2.7. Others

14.7.7.6. Benelux Union Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Country

14.7.7.6.1. Belgium

14.7.7.6.2. The Netherlands

14.7.7.6.3. Luxembourg

14.7.8. Rest of Europe

14.7.8.1. Rest of Europe Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

14.7.8.1.1. Allergens, antigens, vaccines and hormones

14.7.8.1.2. Cytokines, enzymes and human whole-blood

14.7.8.1.3. Plasma derivative

14.7.8.1.4. Immune sera, immunoglobulins and products of fermentation

14.7.8.1.5. Others (diagnostic agents for in vitro use, etc.)

14.7.8.2. Rest of Europe Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

14.7.8.2.1. Consumables and Instruments

14.7.8.2.2. Solution

14.7.8.2.3. Services

14.7.8.3. Rest of Europe Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

14.7.8.3.1. GC/MS

14.7.8.3.2.  LC/MS/ High Performance Liquid (HPLC)

14.7.8.3.3. Ultra High Performance Liquid (UHPLC)

14.7.8.3.4. Supercritical Fluid (SFC) chromatography

14.7.8.3.5. Elemental analysis techniques

14.7.8.3.6. Others

14.7.8.4. Rest of Europe Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

14.7.8.4.1. Elemental Impurities

14.7.8.4.2. Volatile Organic Impurities

14.7.8.4.3. Extractables and Leachables

14.7.8.4.4. Semi-Volatile Organic Impurites

14.7.8.4.5. Non-Volatile Organic Impurites

14.7.8.4.6. Counterion Analysis

14.7.8.4.7. Others

14.7.8.5. Rest of Europe Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

14.7.8.5.1. Pharmaceutical Microbiology

14.7.8.5.1.1. Sterility Testing

14.7.8.5.1.2. Antimicrobial Efficacy Testing (AET)

14.7.8.5.1.3. Microbial Limits Testing

14.7.8.5.1.4. Bioburden Determination

14.7.8.5.1.5. Endotoxin Testing

14.7.8.5.1.6. Environmental Monitoring and Identification

14.7.8.5.1.7. Packaging Testing

14.7.8.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

14.7.8.5.1.9. Pharmaceutical Gas Testing

14.7.8.5.1.10. Viral Safety Testing and Lot Release Testing

14.7.8.5.1.11. Others (Water Analysis and etc.)

14.7.8.5.2. Pharmaceutical Chemistry

14.7.8.5.2.1. Elemental Impurities

14.7.8.5.2.2. Volatile Organic Impurities

14.7.8.5.2.3. Extractables and Leachables

14.7.8.5.2.4. Semi-Volatile Organic Impurites

14.7.8.5.2.5. Non-Volatile Organic Impurites

14.7.8.5.2.6. Counterion Analysis

14.7.8.5.2.7. Others

14.8. Key Segment for Channeling Investments

14.8.1. By Country

14.8.2. By Application

14.8.3. By Offering

14.8.4. By  Techniques

14.8.5. By Testing Categories

14.8.6. By Analysis Type

15. Asia Pacific Pharmaceutical Quality Control Market Analysis and Forecasts, 2021 - 2029

15.1. Overview

15.1.1. Asia Pacific Pharmaceutical Quality Control Market Revenue (US$ Mn)

15.2. Asia Pacific Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

15.2.1. Allergens, antigens, vaccines and hormones

15.2.2. Cytokines, enzymes and human whole-blood

15.2.3. Plasma derivative

15.2.4. Immune sera, immunoglobulins and products of fermentation

15.2.5. Others (diagnostic agents for in vitro use, etc.)

15.3. Asia Pacific Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

15.3.1. Consumables and Instruments

15.3.2. Solution

15.3.3. Services

15.4. Asia Pacific Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

15.4.1. GC/MS

15.4.2.  LC/MS/ High Performance Liquid (HPLC)

15.4.3. Ultra High Performance Liquid (UHPLC)

15.4.4. Supercritical Fluid (SFC) chromatography

15.4.5. Elemental analysis techniques

15.4.6. Others

15.5. Asia Pacific Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

15.5.1. Elemental Impurities

15.5.2. Volatile Organic Impurities

15.5.3. Extractables and Leachables

15.5.4. Semi-Volatile Organic Impurites

15.5.5. Non-Volatile Organic Impurites

15.5.6. Counterion Analysis

15.5.7. Others

15.6. Asia Pacific Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

15.6.1. Pharmaceutical Microbiology

15.6.1.1. Sterility Testing

15.6.1.2. Antimicrobial Efficacy Testing (AET)

15.6.1.3. Microbial Limits Testing

15.6.1.4. Bioburden Determination

15.6.1.5. Endotoxin Testing

15.6.1.6. Environmental Monitoring and Identification

15.6.1.7. Packaging Testing

15.6.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

15.6.1.9. Pharmaceutical Gas Testing

15.6.1.10.             Viral Safety Testing and Lot Release Testing

15.6.1.11.             Others (Water Analysis and etc.)

15.6.2. Pharmaceutical Chemistry

15.6.2.1. Elemental Impurities

15.6.2.2. Volatile Organic Impurities

15.6.2.3. Extractables and Leachables

15.6.2.4. Semi-Volatile Organic Impurites

15.6.2.5. Non-Volatile Organic Impurites

15.6.2.6. Counterion Analysis

15.6.2.7. Others

15.7. Asia Pacific Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Country

15.7.1. China

15.7.1.1. China Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

15.7.1.1.1. Allergens, antigens, vaccines and hormones

15.7.1.1.2. Cytokines, enzymes and human whole-blood

15.7.1.1.3. Plasma derivative

15.7.1.1.4. Immune sera, immunoglobulins and products of fermentation

15.7.1.1.5. Others (diagnostic agents for in vitro use, etc.)

15.7.1.2. China Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

15.7.1.2.1. Consumables and Instruments

15.7.1.2.2. Solution

15.7.1.2.3. Services

15.7.1.3. China Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

15.7.1.3.1. GC/MS

15.7.1.3.2.  LC/MS/ High Performance Liquid (HPLC)

15.7.1.3.3. Ultra High Performance Liquid (UHPLC)

15.7.1.3.4. Supercritical Fluid (SFC) chromatography

15.7.1.3.5. Elemental analysis techniques

15.7.1.3.6. Others

15.7.1.4. China Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

15.7.1.4.1. Elemental Impurities

15.7.1.4.2. Volatile Organic Impurities

15.7.1.4.3. Extractables and Leachables

15.7.1.4.4. Semi-Volatile Organic Impurites

15.7.1.4.5. Non-Volatile Organic Impurites

15.7.1.4.6. Counterion Analysis

15.7.1.4.7. Others

15.7.1.5. China Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

15.7.1.5.1. Pharmaceutical Microbiology

15.7.1.5.1.1. Sterility Testing

15.7.1.5.1.2. Antimicrobial Efficacy Testing (AET)

15.7.1.5.1.3. Microbial Limits Testing

15.7.1.5.1.4. Bioburden Determination

15.7.1.5.1.5. Endotoxin Testing

15.7.1.5.1.6. Environmental Monitoring and Identification

15.7.1.5.1.7. Packaging Testing

15.7.1.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

15.7.1.5.1.9. Pharmaceutical Gas Testing

15.7.1.5.1.10. Viral Safety Testing and Lot Release Testing

15.7.1.5.1.11. Others (Water Analysis and etc.)

15.7.1.5.2. Pharmaceutical Chemistry

15.7.1.5.2.1. Elemental Impurities

15.7.1.5.2.2. Volatile Organic Impurities

15.7.1.5.2.3. Extractables and Leachables

15.7.1.5.2.4. Semi-Volatile Organic Impurites

15.7.1.5.2.5. Non-Volatile Organic Impurites

15.7.1.5.2.6. Counterion Analysis

15.7.1.5.2.7. Others

15.7.2. Japan

15.7.2.1. Japan Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

15.7.2.1.1. Allergens, antigens, vaccines and hormones

15.7.2.1.2. Cytokines, enzymes and human whole-blood

15.7.2.1.3. Plasma derivative

15.7.2.1.4. Immune sera, immunoglobulins and products of fermentation

15.7.2.1.5. Others (diagnostic agents for in vitro use, etc.)

15.7.2.2. Japan Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

15.7.2.2.1. Consumables and Instruments

15.7.2.2.2. Solution

15.7.2.2.3. Services

15.7.2.3. Japan Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

15.7.2.3.1. GC/MS

15.7.2.3.2.  LC/MS/ High Performance Liquid (HPLC)

15.7.2.3.3. Ultra High Performance Liquid (UHPLC)

15.7.2.3.4. Supercritical Fluid (SFC) chromatography

15.7.2.3.5. Elemental analysis techniques

15.7.2.3.6. Others

15.7.2.4. Japan Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

15.7.2.4.1. Elemental Impurities

15.7.2.4.2. Volatile Organic Impurities

15.7.2.4.3. Extractables and Leachables

15.7.2.4.4. Semi-Volatile Organic Impurites

15.7.2.4.5. Non-Volatile Organic Impurites

15.7.2.4.6. Counterion Analysis

15.7.2.4.7. Others

15.7.2.5. Japan Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

15.7.2.5.1. Pharmaceutical Microbiology

15.7.2.5.1.1. Sterility Testing

15.7.2.5.1.2. Antimicrobial Efficacy Testing (AET)

15.7.2.5.1.3. Microbial Limits Testing

15.7.2.5.1.4. Bioburden Determination

15.7.2.5.1.5. Endotoxin Testing

15.7.2.5.1.6. Environmental Monitoring and Identification

15.7.2.5.1.7. Packaging Testing

15.7.2.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

15.7.2.5.1.9. Pharmaceutical Gas Testing

15.7.2.5.1.10. Viral Safety Testing and Lot Release Testing

15.7.2.5.1.11. Others (Water Analysis and etc.)

15.7.2.5.2. Pharmaceutical Chemistry

15.7.2.5.2.1. Elemental Impurities

15.7.2.5.2.2. Volatile Organic Impurities

15.7.2.5.2.3. Extractables and Leachables

15.7.2.5.2.4. Semi-Volatile Organic Impurites

15.7.2.5.2.5. Non-Volatile Organic Impurites

15.7.2.5.2.6. Counterion Analysis

15.7.2.5.2.7. Others

15.7.3. India

15.7.3.1. India Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

15.7.3.1.1. Allergens, antigens, vaccines and hormones

15.7.3.1.2. Cytokines, enzymes and human whole-blood

15.7.3.1.3. Plasma derivative

15.7.3.1.4. Immune sera, immunoglobulins and products of fermentation

15.7.3.1.5. Others (diagnostic agents for in vitro use, etc.)

15.7.3.2. India Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

15.7.3.2.1. Consumables and Instruments

15.7.3.2.2. Solution

15.7.3.2.3. Services

15.7.3.3. India Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

15.7.3.3.1. GC/MS

15.7.3.3.2.  LC/MS/ High Performance Liquid (HPLC)

15.7.3.3.3. Ultra High Performance Liquid (UHPLC)

15.7.3.3.4. Supercritical Fluid (SFC) chromatography

15.7.3.3.5. Elemental analysis techniques

15.7.3.3.6. Others

15.7.3.4. India Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

15.7.3.4.1. Elemental Impurities

15.7.3.4.2. Volatile Organic Impurities

15.7.3.4.3. Extractables and Leachables

15.7.3.4.4. Semi-Volatile Organic Impurites

15.7.3.4.5. Non-Volatile Organic Impurites

15.7.3.4.6. Counterion Analysis

15.7.3.4.7. Others

15.7.3.5. India Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

15.7.3.5.1. Pharmaceutical Microbiology

15.7.3.5.1.1. Sterility Testing

15.7.3.5.1.2. Antimicrobial Efficacy Testing (AET)

15.7.3.5.1.3. Microbial Limits Testing

15.7.3.5.1.4. Bioburden Determination

15.7.3.5.1.5. Endotoxin Testing

15.7.3.5.1.6. Environmental Monitoring and Identification

15.7.3.5.1.7. Packaging Testing

15.7.3.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

15.7.3.5.1.9. Pharmaceutical Gas Testing

15.7.3.5.1.10. Viral Safety Testing and Lot Release Testing

15.7.3.5.1.11. Others (Water Analysis and etc.)

15.7.3.5.2. Pharmaceutical Chemistry

15.7.3.5.2.1. Elemental Impurities

15.7.3.5.2.2. Volatile Organic Impurities

15.7.3.5.2.3. Extractables and Leachables

15.7.3.5.2.4. Semi-Volatile Organic Impurites

15.7.3.5.2.5. Non-Volatile Organic Impurites

15.7.3.5.2.6. Counterion Analysis

15.7.3.5.2.7. Others

15.7.4. New Zealand

15.7.4.1. New Zealand Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

15.7.4.1.1. Allergens, antigens, vaccines and hormones

15.7.4.1.2. Cytokines, enzymes and human whole-blood

15.7.4.1.3. Plasma derivative

15.7.4.1.4. Immune sera, immunoglobulins and products of fermentation

15.7.4.1.5. Others (diagnostic agents for in vitro use, etc.)

15.7.4.2. New Zealand Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

15.7.4.2.1. Consumables and Instruments

15.7.4.2.2. Solution

15.7.4.2.3. Services

15.7.4.3. New Zealand Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

15.7.4.3.1. GC/MS

15.7.4.3.2.  LC/MS/ High Performance Liquid (HPLC)

15.7.4.3.3. Ultra High Performance Liquid (UHPLC)

15.7.4.3.4. Supercritical Fluid (SFC) chromatography

15.7.4.3.5. Elemental analysis techniques

15.7.4.3.6. Others

15.7.4.4. New Zealand Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

15.7.4.4.1. Elemental Impurities

15.7.4.4.2. Volatile Organic Impurities

15.7.4.4.3. Extractables and Leachables

15.7.4.4.4. Semi-Volatile Organic Impurites

15.7.4.4.5. Non-Volatile Organic Impurites

15.7.4.4.6. Counterion Analysis

15.7.4.4.7. Others

15.7.4.5. New Zealand Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

15.7.4.5.1. Pharmaceutical Microbiology

15.7.4.5.1.1. Sterility Testing

15.7.4.5.1.2. Antimicrobial Efficacy Testing (AET)

15.7.4.5.1.3. Microbial Limits Testing

15.7.4.5.1.4. Bioburden Determination

15.7.4.5.1.5. Endotoxin Testing

15.7.4.5.1.6. Environmental Monitoring and Identification

15.7.4.5.1.7. Packaging Testing

15.7.4.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

15.7.4.5.1.9. Pharmaceutical Gas Testing

15.7.4.5.1.10. Viral Safety Testing and Lot Release Testing

15.7.4.5.1.11. Others (Water Analysis and etc.)

15.7.4.5.2. Pharmaceutical Chemistry

15.7.4.5.2.1. Elemental Impurities

15.7.4.5.2.2. Volatile Organic Impurities

15.7.4.5.2.3. Extractables and Leachables

15.7.4.5.2.4. Semi-Volatile Organic Impurites

15.7.4.5.2.5. Non-Volatile Organic Impurites

15.7.4.5.2.6. Counterion Analysis

15.7.4.5.2.7. Others

15.7.5. Australia

15.7.5.1. Australia Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

15.7.5.1.1. Allergens, antigens, vaccines and hormones

15.7.5.1.2. Cytokines, enzymes and human whole-blood

15.7.5.1.3. Plasma derivative

15.7.5.1.4. Immune sera, immunoglobulins and products of fermentation

15.7.5.1.5. Others (diagnostic agents for in vitro use, etc.)

15.7.5.2. Australia Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

15.7.5.2.1. Consumables and Instruments

15.7.5.2.2. Solution

15.7.5.2.3. Services

15.7.5.3. Australia Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

15.7.5.3.1. GC/MS

15.7.5.3.2.  LC/MS/ High Performance Liquid (HPLC)

15.7.5.3.3. Ultra High Performance Liquid (UHPLC)

15.7.5.3.4. Supercritical Fluid (SFC) chromatography

15.7.5.3.5. Elemental analysis techniques

15.7.5.3.6. Others

15.7.5.4. Australia Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

15.7.5.4.1. Elemental Impurities

15.7.5.4.2. Volatile Organic Impurities

15.7.5.4.3. Extractables and Leachables

15.7.5.4.4. Semi-Volatile Organic Impurites

15.7.5.4.5. Non-Volatile Organic Impurites

15.7.5.4.6. Counterion Analysis

15.7.5.4.7. Others

15.7.5.5. Australia Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

15.7.5.5.1. Pharmaceutical Microbiology

15.7.5.5.1.1. Sterility Testing

15.7.5.5.1.2. Antimicrobial Efficacy Testing (AET)

15.7.5.5.1.3. Microbial Limits Testing

15.7.5.5.1.4. Bioburden Determination

15.7.5.5.1.5. Endotoxin Testing

15.7.5.5.1.6. Environmental Monitoring and Identification

15.7.5.5.1.7. Packaging Testing

15.7.5.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

15.7.5.5.1.9. Pharmaceutical Gas Testing

15.7.5.5.1.10. Viral Safety Testing and Lot Release Testing

15.7.5.5.1.11. Others (Water Analysis and etc.)

15.7.5.5.2. Pharmaceutical Chemistry

15.7.5.5.2.1. Elemental Impurities

15.7.5.5.2.2. Volatile Organic Impurities

15.7.5.5.2.3. Extractables and Leachables

15.7.5.5.2.4. Semi-Volatile Organic Impurites

15.7.5.5.2.5. Non-Volatile Organic Impurites

15.7.5.5.2.6. Counterion Analysis

15.7.5.5.2.7. Others

15.7.6. South Korea

15.7.6.1. South Korea Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

15.7.6.1.1. Allergens, antigens, vaccines and hormones

15.7.6.1.2. Cytokines, enzymes and human whole-blood

15.7.6.1.3. Plasma derivative

15.7.6.1.4. Immune sera, immunoglobulins and products of fermentation

15.7.6.1.5. Others (diagnostic agents for in vitro use, etc.)

15.7.6.2. South Korea Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

15.7.6.2.1. Consumables and Instruments

15.7.6.2.2. Solution

15.7.6.2.3. Services

15.7.6.3. South Korea Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

15.7.6.3.1. GC/MS

15.7.6.3.2.  LC/MS/ High Performance Liquid (HPLC)

15.7.6.3.3. Ultra High Performance Liquid (UHPLC)

15.7.6.3.4. Supercritical Fluid (SFC) chromatography

15.7.6.3.5. Elemental analysis techniques

15.7.6.3.6. Others

15.7.6.4. South Korea Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

15.7.6.4.1. Elemental Impurities

15.7.6.4.2. Volatile Organic Impurities

15.7.6.4.3. Extractables and Leachables

15.7.6.4.4. Semi-Volatile Organic Impurites

15.7.6.4.5. Non-Volatile Organic Impurites

15.7.6.4.6. Counterion Analysis

15.7.6.4.7. Others

15.7.6.5. South Korea Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

15.7.6.5.1. Pharmaceutical Microbiology

15.7.6.5.1.1. Sterility Testing

15.7.6.5.1.2. Antimicrobial Efficacy Testing (AET)

15.7.6.5.1.3. Microbial Limits Testing

15.7.6.5.1.4. Bioburden Determination

15.7.6.5.1.5. Endotoxin Testing

15.7.6.5.1.6. Environmental Monitoring and Identification

15.7.6.5.1.7. Packaging Testing

15.7.6.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

15.7.6.5.1.9. Pharmaceutical Gas Testing

15.7.6.5.1.10. Viral Safety Testing and Lot Release Testing

15.7.6.5.1.11. Others (Water Analysis and etc.)

15.7.6.5.2. Pharmaceutical Chemistry

15.7.6.5.2.1. Elemental Impurities

15.7.6.5.2.2. Volatile Organic Impurities

15.7.6.5.2.3. Extractables and Leachables

15.7.6.5.2.4. Semi-Volatile Organic Impurites

15.7.6.5.2.5. Non-Volatile Organic Impurites

15.7.6.5.2.6. Counterion Analysis

15.7.6.5.2.7. Others

15.7.7. Southeast Asia

15.7.7.1. Southeast Asia Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

15.7.7.1.1. Allergens, antigens, vaccines and hormones

15.7.7.1.2. Cytokines, enzymes and human whole-blood

15.7.7.1.3. Plasma derivative

15.7.7.1.4. Immune sera, immunoglobulins and products of fermentation

15.7.7.1.5. Others (diagnostic agents for in vitro use, etc.)

15.7.7.2. Southeast Asia Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

15.7.7.2.1. Consumables and Instruments

15.7.7.2.2. Solution

15.7.7.2.3. Services

15.7.7.3. Southeast Asia Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

15.7.7.3.1. GC/MS

15.7.7.3.2.  LC/MS/ High Performance Liquid (HPLC)

15.7.7.3.3. Ultra High Performance Liquid (UHPLC)

15.7.7.3.4. Supercritical Fluid (SFC) chromatography

15.7.7.3.5. Elemental analysis techniques

15.7.7.3.6. Others

15.7.7.4. Southeast Asia Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

15.7.7.4.1. Elemental Impurities

15.7.7.4.2. Volatile Organic Impurities

15.7.7.4.3. Extractables and Leachables

15.7.7.4.4. Semi-Volatile Organic Impurites

15.7.7.4.5. Non-Volatile Organic Impurites

15.7.7.4.6. Counterion Analysis

15.7.7.4.7. Others

15.7.7.5. Southeast Asia Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

15.7.7.5.1. Pharmaceutical Microbiology

15.7.7.5.1.1. Sterility Testing

15.7.7.5.1.2. Antimicrobial Efficacy Testing (AET)

15.7.7.5.1.3. Microbial Limits Testing

15.7.7.5.1.4. Bioburden Determination

15.7.7.5.1.5. Endotoxin Testing

15.7.7.5.1.6. Environmental Monitoring and Identification

15.7.7.5.1.7. Packaging Testing

15.7.7.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

15.7.7.5.1.9. Pharmaceutical Gas Testing

15.7.7.5.1.10. Viral Safety Testing and Lot Release Testing

15.7.7.5.1.11. Others (Water Analysis and etc.)

15.7.7.5.2. Pharmaceutical Chemistry

15.7.7.5.2.1. Elemental Impurities

15.7.7.5.2.2. Volatile Organic Impurities

15.7.7.5.2.3. Extractables and Leachables

15.7.7.5.2.4. Semi-Volatile Organic Impurites

15.7.7.5.2.5. Non-Volatile Organic Impurites

15.7.7.5.2.6. Counterion Analysis

15.7.7.5.2.7. Others

15.7.7.6. Southeast Asia Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Country

15.7.7.6.1. Indonesia

15.7.7.6.2. Thailand

15.7.7.6.3. Malaysia

15.7.7.6.4. Singapore

15.7.7.6.5. Rest of Southeast Asia

15.7.8. Rest of Asia Pacific

15.7.8.1. Rest of Asia Pacific Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

15.7.8.1.1. Allergens, antigens, vaccines and hormones

15.7.8.1.2. Cytokines, enzymes and human whole-blood

15.7.8.1.3. Plasma derivative

15.7.8.1.4. Immune sera, immunoglobulins and products of fermentation

15.7.8.1.5. Others (diagnostic agents for in vitro use, etc.)

15.7.8.2. Rest of Asia Pacific Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

15.7.8.2.1. Consumables and Instruments

15.7.8.2.2. Solution

15.7.8.2.3. Services

15.7.8.3. Rest of Asia Pacific Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

15.7.8.3.1. GC/MS

15.7.8.3.2.  LC/MS/ High Performance Liquid (HPLC)

15.7.8.3.3. Ultra High Performance Liquid (UHPLC)

15.7.8.3.4. Supercritical Fluid (SFC) chromatography

15.7.8.3.5. Elemental analysis techniques

15.7.8.3.6. Others

15.7.8.4. Rest of Asia Pacific Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

15.7.8.4.1. Elemental Impurities

15.7.8.4.2. Volatile Organic Impurities

15.7.8.4.3. Extractables and Leachables

15.7.8.4.4. Semi-Volatile Organic Impurites

15.7.8.4.5. Non-Volatile Organic Impurites

15.7.8.4.6. Counterion Analysis

15.7.8.4.7. Others

15.7.8.5. Rest of Asia Pacific Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

15.7.8.5.1. Pharmaceutical Microbiology

15.7.8.5.1.1. Sterility Testing

15.7.8.5.1.2. Antimicrobial Efficacy Testing (AET)

15.7.8.5.1.3. Microbial Limits Testing

15.7.8.5.1.4. Bioburden Determination

15.7.8.5.1.5. Endotoxin Testing

15.7.8.5.1.6. Environmental Monitoring and Identification

15.7.8.5.1.7. Packaging Testing

15.7.8.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

15.7.8.5.1.9. Pharmaceutical Gas Testing

15.7.8.5.1.10. Viral Safety Testing and Lot Release Testing

15.7.8.5.1.11. Others (Water Analysis and etc.)

15.7.8.5.2. Pharmaceutical Chemistry

15.7.8.5.2.1. Elemental Impurities

15.7.8.5.2.2. Volatile Organic Impurities

15.7.8.5.2.3. Extractables and Leachables

15.7.8.5.2.4. Semi-Volatile Organic Impurites

15.7.8.5.2.5. Non-Volatile Organic Impurites

15.7.8.5.2.6. Counterion Analysis

15.7.8.5.2.7. Others

15.8. Key Segment for Channeling Investments

15.8.1. By Country

15.8.2. By Application

15.8.3. By Offering

15.8.4. By  Techniques

15.8.5. By Testing Categories

15.8.6. By Analysis Type

16. Middle East and Africa Pharmaceutical Quality Control Market Analysis and Forecasts, 2021 - 2029

16.1. Overview

16.1.1. Middle East and Africa Pharmaceutical Quality Control Market Revenue (US$ Mn)

16.2. Middle East and Africa Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

16.2.1. Allergens, antigens, vaccines and hormones

16.2.2. Cytokines, enzymes and human whole-blood

16.2.3. Plasma derivative

16.2.4. Immune sera, immunoglobulins and products of fermentation

16.2.5. Others (diagnostic agents for in vitro use, etc.)

16.3. Middle East and Africa Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

16.3.1. Consumables and Instruments

16.3.2. Solution

16.3.3. Services

16.4. Middle East and Africa Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

16.4.1. GC/MS

16.4.2.  LC/MS/ High Performance Liquid (HPLC)

16.4.3. Ultra High Performance Liquid (UHPLC)

16.4.4. Supercritical Fluid (SFC) chromatography

16.4.5. Elemental analysis techniques

16.4.6. Others

16.5. Middle East and Africa Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

16.5.1. Elemental Impurities

16.5.2. Volatile Organic Impurities

16.5.3. Extractables and Leachables

16.5.4. Semi-Volatile Organic Impurites

16.5.5. Non-Volatile Organic Impurites

16.5.6. Counterion Analysis

16.5.7. Others

16.6. Middle East and Africa Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

16.6.1. Pharmaceutical Microbiology

16.6.1.1. Sterility Testing

16.6.1.2. Antimicrobial Efficacy Testing (AET)

16.6.1.3. Microbial Limits Testing

16.6.1.4. Bioburden Determination

16.6.1.5. Endotoxin Testing

16.6.1.6. Environmental Monitoring and Identification

16.6.1.7. Packaging Testing

16.6.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

16.6.1.9. Pharmaceutical Gas Testing

16.6.1.10.             Viral Safety Testing and Lot Release Testing

16.6.1.11.             Others (Water Analysis and etc.)

16.6.2. Pharmaceutical Chemistry

16.6.2.1. Elemental Impurities

16.6.2.2. Volatile Organic Impurities

16.6.2.3. Extractables and Leachables

16.6.2.4. Semi-Volatile Organic Impurites

16.6.2.5. Non-Volatile Organic Impurites

16.6.2.6. Counterion Analysis

16.6.2.7. Others

16.7. Middle East and Africa Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Country

16.7.1. Saudi Arabia

16.7.1.1. Saudi Arabia Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

16.7.1.1.1. Allergens, antigens, vaccines and hormones

16.7.1.1.2. Cytokines, enzymes and human whole-blood

16.7.1.1.3. Plasma derivative

16.7.1.1.4. Immune sera, immunoglobulins and products of fermentation

16.7.1.1.5. Others (diagnostic agents for in vitro use, etc.)

16.7.1.2. Saudi Arabia Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

16.7.1.2.1. Consumables and Instruments

16.7.1.2.2. Solution

16.7.1.2.3. Services

16.7.1.3. Saudi Arabia Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

16.7.1.3.1. GC/MS

16.7.1.3.2.  LC/MS/ High Performance Liquid (HPLC)

16.7.1.3.3. Ultra High Performance Liquid (UHPLC)

16.7.1.3.4. Supercritical Fluid (SFC) chromatography

16.7.1.3.5. Elemental analysis techniques

16.7.1.3.6. Others

16.7.1.4. Saudi Arabia Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

16.7.1.4.1. Elemental Impurities

16.7.1.4.2. Volatile Organic Impurities

16.7.1.4.3. Extractables and Leachables

16.7.1.4.4. Semi-Volatile Organic Impurites

16.7.1.4.5. Non-Volatile Organic Impurites

16.7.1.4.6. Counterion Analysis

16.7.1.4.7. Others

16.7.1.5. Saudi Arabia Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

16.7.1.5.1. Pharmaceutical Microbiology

16.7.1.5.1.1. Sterility Testing

16.7.1.5.1.2. Antimicrobial Efficacy Testing (AET)

16.7.1.5.1.3. Microbial Limits Testing

16.7.1.5.1.4. Bioburden Determination

16.7.1.5.1.5. Endotoxin Testing

16.7.1.5.1.6. Environmental Monitoring and Identification

16.7.1.5.1.7. Packaging Testing

16.7.1.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

16.7.1.5.1.9. Pharmaceutical Gas Testing

16.7.1.5.1.10. Viral Safety Testing and Lot Release Testing

16.7.1.5.1.11. Others (Water Analysis and etc.)

16.7.1.5.2. Pharmaceutical Chemistry

16.7.1.5.2.1. Elemental Impurities

16.7.1.5.2.2. Volatile Organic Impurities

16.7.1.5.2.3. Extractables and Leachables

16.7.1.5.2.4. Semi-Volatile Organic Impurites

16.7.1.5.2.5. Non-Volatile Organic Impurites

16.7.1.5.2.6. Counterion Analysis

16.7.1.5.2.7. Others

16.7.2. UAE

16.7.2.1. UAE Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

16.7.2.1.1. Allergens, antigens, vaccines and hormones

16.7.2.1.2. Cytokines, enzymes and human whole-blood

16.7.2.1.3. Plasma derivative

16.7.2.1.4. Immune sera, immunoglobulins and products of fermentation

16.7.2.1.5. Others (diagnostic agents for in vitro use, etc.)

16.7.2.2. UAE Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

16.7.2.2.1. Consumables and Instruments

16.7.2.2.2. Solution

16.7.2.2.3. Services

16.7.2.3. UAE Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

16.7.2.3.1. GC/MS

16.7.2.3.2.  LC/MS/ High Performance Liquid (HPLC)

16.7.2.3.3. Ultra High Performance Liquid (UHPLC)

16.7.2.3.4. Supercritical Fluid (SFC) chromatography

16.7.2.3.5. Elemental analysis techniques

16.7.2.3.6. Others

16.7.2.4. UAE Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

16.7.2.4.1. Elemental Impurities

16.7.2.4.2. Volatile Organic Impurities

16.7.2.4.3. Extractables and Leachables

16.7.2.4.4. Semi-Volatile Organic Impurites

16.7.2.4.5. Non-Volatile Organic Impurites

16.7.2.4.6. Counterion Analysis

16.7.2.4.7. Others

16.7.2.5. UAE Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

16.7.2.5.1. Pharmaceutical Microbiology

16.7.2.5.1.1. Sterility Testing

16.7.2.5.1.2. Antimicrobial Efficacy Testing (AET)

16.7.2.5.1.3. Microbial Limits Testing

16.7.2.5.1.4. Bioburden Determination

16.7.2.5.1.5. Endotoxin Testing

16.7.2.5.1.6. Environmental Monitoring and Identification

16.7.2.5.1.7. Packaging Testing

16.7.2.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

16.7.2.5.1.9. Pharmaceutical Gas Testing

16.7.2.5.1.10. Viral Safety Testing and Lot Release Testing

16.7.2.5.1.11. Others (Water Analysis and etc.)

16.7.2.5.2. Pharmaceutical Chemistry

16.7.2.5.2.1. Elemental Impurities

16.7.2.5.2.2. Volatile Organic Impurities

16.7.2.5.2.3. Extractables and Leachables

16.7.2.5.2.4. Semi-Volatile Organic Impurites

16.7.2.5.2.5. Non-Volatile Organic Impurites

16.7.2.5.2.6. Counterion Analysis

16.7.2.5.2.7. Others

16.7.3. Egypt

16.7.3.1. Egypt Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

16.7.3.1.1. Allergens, antigens, vaccines and hormones

16.7.3.1.2. Cytokines, enzymes and human whole-blood

16.7.3.1.3. Plasma derivative

16.7.3.1.4. Immune sera, immunoglobulins and products of fermentation

16.7.3.1.5. Others (diagnostic agents for in vitro use, etc.)

16.7.3.2. Egypt Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

16.7.3.2.1. Consumables and Instruments

16.7.3.2.2. Solution

16.7.3.2.3. Services

16.7.3.3. Egypt Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

16.7.3.3.1. GC/MS

16.7.3.3.2.  LC/MS/ High Performance Liquid (HPLC)

16.7.3.3.3. Ultra High Performance Liquid (UHPLC)

16.7.3.3.4. Supercritical Fluid (SFC) chromatography

16.7.3.3.5. Elemental analysis techniques

16.7.3.3.6. Others

16.7.3.4. Egypt Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

16.7.3.4.1. Elemental Impurities

16.7.3.4.2. Volatile Organic Impurities

16.7.3.4.3. Extractables and Leachables

16.7.3.4.4. Semi-Volatile Organic Impurites

16.7.3.4.5. Non-Volatile Organic Impurites

16.7.3.4.6. Counterion Analysis

16.7.3.4.7. Others

16.7.3.5. Egypt Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

16.7.3.5.1. Pharmaceutical Microbiology

16.7.3.5.1.1. Sterility Testing

16.7.3.5.1.2. Antimicrobial Efficacy Testing (AET)

16.7.3.5.1.3. Microbial Limits Testing

16.7.3.5.1.4. Bioburden Determination

16.7.3.5.1.5. Endotoxin Testing

16.7.3.5.1.6. Environmental Monitoring and Identification

16.7.3.5.1.7. Packaging Testing

16.7.3.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

16.7.3.5.1.9. Pharmaceutical Gas Testing

16.7.3.5.1.10. Viral Safety Testing and Lot Release Testing

16.7.3.5.1.11. Others (Water Analysis and etc.)

16.7.3.5.2. Pharmaceutical Chemistry

16.7.3.5.2.1. Elemental Impurities

16.7.3.5.2.2. Volatile Organic Impurities

16.7.3.5.2.3. Extractables and Leachables

16.7.3.5.2.4. Semi-Volatile Organic Impurites

16.7.3.5.2.5. Non-Volatile Organic Impurites

16.7.3.5.2.6. Counterion Analysis

16.7.3.5.2.7. Others

16.7.4. Kuwait

16.7.4.1. Kuwait Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

16.7.4.1.1. Allergens, antigens, vaccines and hormones

16.7.4.1.2. Cytokines, enzymes and human whole-blood

16.7.4.1.3. Plasma derivative

16.7.4.1.4. Immune sera, immunoglobulins and products of fermentation

16.7.4.1.5. Others (diagnostic agents for in vitro use, etc.)

16.7.4.2. Kuwait Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

16.7.4.2.1. Consumables and Instruments

16.7.4.2.2. Solution

16.7.4.2.3. Services

16.7.4.3. Kuwait Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

16.7.4.3.1. GC/MS

16.7.4.3.2.  LC/MS/ High Performance Liquid (HPLC)

16.7.4.3.3. Ultra High Performance Liquid (UHPLC)

16.7.4.3.4. Supercritical Fluid (SFC) chromatography

16.7.4.3.5. Elemental analysis techniques

16.7.4.3.6. Others

16.7.4.4. Kuwait Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

16.7.4.4.1. Elemental Impurities

16.7.4.4.2. Volatile Organic Impurities

16.7.4.4.3. Extractables and Leachables

16.7.4.4.4. Semi-Volatile Organic Impurites

16.7.4.4.5. Non-Volatile Organic Impurites

16.7.4.4.6. Counterion Analysis

16.7.4.4.7. Others

16.7.4.5. Kuwait Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

16.7.4.5.1. Pharmaceutical Microbiology

16.7.4.5.1.1. Sterility Testing

16.7.4.5.1.2. Antimicrobial Efficacy Testing (AET)

16.7.4.5.1.3. Microbial Limits Testing

16.7.4.5.1.4. Bioburden Determination

16.7.4.5.1.5. Endotoxin Testing

16.7.4.5.1.6. Environmental Monitoring and Identification

16.7.4.5.1.7. Packaging Testing

16.7.4.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

16.7.4.5.1.9. Pharmaceutical Gas Testing

16.7.4.5.1.10. Viral Safety Testing and Lot Release Testing

16.7.4.5.1.11. Others (Water Analysis and etc.)

16.7.4.5.2. Pharmaceutical Chemistry

16.7.4.5.2.1. Elemental Impurities

16.7.4.5.2.2. Volatile Organic Impurities

16.7.4.5.2.3. Extractables and Leachables

16.7.4.5.2.4. Semi-Volatile Organic Impurites

16.7.4.5.2.5. Non-Volatile Organic Impurites

16.7.4.5.2.6. Counterion Analysis

16.7.4.5.2.7. Others

16.7.5. South Africa

16.7.5.1. South Africa Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

16.7.5.1.1. Allergens, antigens, vaccines and hormones

16.7.5.1.2. Cytokines, enzymes and human whole-blood

16.7.5.1.3. Plasma derivative

16.7.5.1.4. Immune sera, immunoglobulins and products of fermentation

16.7.5.1.5. Others (diagnostic agents for in vitro use, etc.)

16.7.5.2. South Africa Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

16.7.5.2.1. Consumables and Instruments

16.7.5.2.2. Solution

16.7.5.2.3. Services

16.7.5.3. South Africa Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

16.7.5.3.1. GC/MS

16.7.5.3.2.  LC/MS/ High Performance Liquid (HPLC)

16.7.5.3.3. Ultra High Performance Liquid (UHPLC)

16.7.5.3.4. Supercritical Fluid (SFC) chromatography

16.7.5.3.5. Elemental analysis techniques

16.7.5.3.6. Others

16.7.5.4. South Africa Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

16.7.5.4.1. Elemental Impurities

16.7.5.4.2. Volatile Organic Impurities

16.7.5.4.3. Extractables and Leachables

16.7.5.4.4. Semi-Volatile Organic Impurites

16.7.5.4.5. Non-Volatile Organic Impurites

16.7.5.4.6. Counterion Analysis

16.7.5.4.7. Others

16.7.5.5. South Africa Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

16.7.5.5.1. Pharmaceutical Microbiology

16.7.5.5.1.1. Sterility Testing

16.7.5.5.1.2. Antimicrobial Efficacy Testing (AET)

16.7.5.5.1.3. Microbial Limits Testing

16.7.5.5.1.4. Bioburden Determination

16.7.5.5.1.5. Endotoxin Testing

16.7.5.5.1.6. Environmental Monitoring and Identification

16.7.5.5.1.7. Packaging Testing

16.7.5.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

16.7.5.5.1.9. Pharmaceutical Gas Testing

16.7.5.5.1.10. Viral Safety Testing and Lot Release Testing

16.7.5.5.1.11. Others (Water Analysis and etc.)

16.7.5.5.2. Pharmaceutical Chemistry

16.7.5.5.2.1. Elemental Impurities

16.7.5.5.2.2. Volatile Organic Impurities

16.7.5.5.2.3. Extractables and Leachables

16.7.5.5.2.4. Semi-Volatile Organic Impurites

16.7.5.5.2.5. Non-Volatile Organic Impurites

16.7.5.5.2.6. Counterion Analysis

16.7.5.5.2.7. Others

16.7.6. Rest of Middle East & Africa

16.7.6.1. Rest of Middle East & Africa Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

16.7.6.1.1. Allergens, antigens, vaccines and hormones

16.7.6.1.2. Cytokines, enzymes and human whole-blood

16.7.6.1.3. Plasma derivative

16.7.6.1.4. Immune sera, immunoglobulins and products of fermentation

16.7.6.1.5. Others (diagnostic agents for in vitro use, etc.)

16.7.6.2. Rest of Middle East & Africa Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

16.7.6.2.1. Consumables and Instruments

16.7.6.2.2. Solution

16.7.6.2.3. Services

16.7.6.3. Rest of Middle East & Africa Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

16.7.6.3.1. GC/MS

16.7.6.3.2.  LC/MS/ High Performance Liquid (HPLC)

16.7.6.3.3. Ultra High Performance Liquid (UHPLC)

16.7.6.3.4. Supercritical Fluid (SFC) chromatography

16.7.6.3.5. Elemental analysis techniques

16.7.6.3.6. Others

16.7.6.4. Rest of Middle East & Africa Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

16.7.6.4.1. Elemental Impurities

16.7.6.4.2. Volatile Organic Impurities

16.7.6.4.3. Extractables and Leachables

16.7.6.4.4. Semi-Volatile Organic Impurites

16.7.6.4.5. Non-Volatile Organic Impurites

16.7.6.4.6. Counterion Analysis

16.7.6.4.7. Others

16.7.6.5. Rest of Middle East & Africa Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

16.7.6.5.1. Pharmaceutical Microbiology

16.7.6.5.1.1. Sterility Testing

16.7.6.5.1.2. Antimicrobial Efficacy Testing (AET)

16.7.6.5.1.3. Microbial Limits Testing

16.7.6.5.1.4. Bioburden Determination

16.7.6.5.1.5. Endotoxin Testing

16.7.6.5.1.6. Environmental Monitoring and Identification

16.7.6.5.1.7. Packaging Testing

16.7.6.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

16.7.6.5.1.9. Pharmaceutical Gas Testing

16.7.6.5.1.10. Viral Safety Testing and Lot Release Testing

16.7.6.5.1.11. Others (Water Analysis and etc.)

16.7.6.5.2. Pharmaceutical Chemistry

16.7.6.5.2.1. Elemental Impurities

16.7.6.5.2.2. Volatile Organic Impurities

16.7.6.5.2.3. Extractables and Leachables

16.7.6.5.2.4. Semi-Volatile Organic Impurites

16.7.6.5.2.5. Non-Volatile Organic Impurites

16.7.6.5.2.6. Counterion Analysis

16.7.6.5.2.7. Others

16.8. Key Segment for Channeling Investments

16.8.1. By Country

16.8.2. By Application

16.8.3. By Offering

16.8.4. By  Techniques

16.8.5. By Testing Categories

16.8.6. By Analysis Type

17. Latin America Pharmaceutical Quality Control Market Analysis and Forecasts, 2021 - 2029

17.1. Overview

17.1.1. Latin America Pharmaceutical Quality Control Market Revenue (US$ Mn)

17.2. Latin America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

17.2.1. Allergens, antigens, vaccines and hormones

17.2.2. Cytokines, enzymes and human whole-blood

17.2.3. Plasma derivative

17.2.4. Immune sera, immunoglobulins and products of fermentation

17.2.5. Others (diagnostic agents for in vitro use, etc.)

17.3. Latin America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

17.3.1. Consumables and Instruments

17.3.2. Solution

17.3.3. Services

17.4. Latin America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

17.4.1. GC/MS

17.4.2.  LC/MS/ High Performance Liquid (HPLC)

17.4.3. Ultra High Performance Liquid (UHPLC)

17.4.4. Supercritical Fluid (SFC) chromatography

17.4.5. Elemental analysis techniques

17.4.6. Others

17.5. Latin America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

17.5.1. Elemental Impurities

17.5.2. Volatile Organic Impurities

17.5.3. Extractables and Leachables

17.5.4. Semi-Volatile Organic Impurites

17.5.5. Non-Volatile Organic Impurites

17.5.6. Counterion Analysis

17.5.7. Others

17.6. Latin America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

17.6.1. Pharmaceutical Microbiology

17.6.1.1. Sterility Testing

17.6.1.2. Antimicrobial Efficacy Testing (AET)

17.6.1.3. Microbial Limits Testing

17.6.1.4. Bioburden Determination

17.6.1.5. Endotoxin Testing

17.6.1.6. Environmental Monitoring and Identification

17.6.1.7. Packaging Testing

17.6.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

17.6.1.9. Pharmaceutical Gas Testing

17.6.1.10.             Viral Safety Testing and Lot Release Testing

17.6.1.11.             Others (Water Analysis and etc.)

17.6.2. Pharmaceutical Chemistry

17.6.2.1. Elemental Impurities

17.6.2.2. Volatile Organic Impurities

17.6.2.3. Extractables and Leachables

17.6.2.4. Semi-Volatile Organic Impurites

17.6.2.5. Non-Volatile Organic Impurites

17.6.2.6. Counterion Analysis

17.6.2.7. Others

17.7. Latin America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Country

17.7.1. Brazil

17.7.1.1. Brazil Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

17.7.1.1.1. Allergens, antigens, vaccines and hormones

17.7.1.1.2. Cytokines, enzymes and human whole-blood

17.7.1.1.3. Plasma derivative

17.7.1.1.4. Immune sera, immunoglobulins and products of fermentation

17.7.1.1.5. Others (diagnostic agents for in vitro use, etc.)

17.7.1.2. Brazil Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

17.7.1.2.1. Consumables and Instruments

17.7.1.2.2. Solution

17.7.1.2.3. Services

17.7.1.3. Brazil Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

17.7.1.3.1. GC/MS

17.7.1.3.2.  LC/MS/ High Performance Liquid (HPLC)

17.7.1.3.3. Ultra High Performance Liquid (UHPLC)

17.7.1.3.4. Supercritical Fluid (SFC) chromatography

17.7.1.3.5. Elemental analysis techniques

17.7.1.3.6. Others

17.7.1.4. Brazil Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

17.7.1.4.1. Elemental Impurities

17.7.1.4.2. Volatile Organic Impurities

17.7.1.4.3. Extractables and Leachables

17.7.1.4.4. Semi-Volatile Organic Impurites

17.7.1.4.5. Non-Volatile Organic Impurites

17.7.1.4.6. Counterion Analysis

17.7.1.4.7. Others

17.7.1.5. Brazil Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

17.7.1.5.1. Pharmaceutical Microbiology

17.7.1.5.1.1. Sterility Testing

17.7.1.5.1.2. Antimicrobial Efficacy Testing (AET)

17.7.1.5.1.3. Microbial Limits Testing

17.7.1.5.1.4. Bioburden Determination

17.7.1.5.1.5. Endotoxin Testing

17.7.1.5.1.6. Environmental Monitoring and Identification

17.7.1.5.1.7. Packaging Testing

17.7.1.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

17.7.1.5.1.9. Pharmaceutical Gas Testing

17.7.1.5.1.10. Viral Safety Testing and Lot Release Testing

17.7.1.5.1.11. Others (Water Analysis and etc.)

17.7.1.5.2. Pharmaceutical Chemistry

17.7.1.5.2.1. Elemental Impurities

17.7.1.5.2.2. Volatile Organic Impurities

17.7.1.5.2.3. Extractables and Leachables

17.7.1.5.2.4. Semi-Volatile Organic Impurites

17.7.1.5.2.5. Non-Volatile Organic Impurites

17.7.1.5.2.6. Counterion Analysis

17.7.1.5.2.7. Others

17.7.2. Argentina

17.7.2.1. Argentina Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

17.7.2.1.1. Allergens, antigens, vaccines and hormones

17.7.2.1.2. Cytokines, enzymes and human whole-blood

17.7.2.1.3. Plasma derivative

17.7.2.1.4. Immune sera, immunoglobulins and products of fermentation

17.7.2.1.5. Others (diagnostic agents for in vitro use, etc.)

17.7.2.2. Argentina Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

17.7.2.2.1. Consumables and Instruments

17.7.2.2.2. Solution

17.7.2.2.3. Services

17.7.2.3. Argentina Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

17.7.2.3.1. GC/MS

17.7.2.3.2.  LC/MS/ High Performance Liquid (HPLC)

17.7.2.3.3. Ultra High Performance Liquid (UHPLC)

17.7.2.3.4. Supercritical Fluid (SFC) chromatography

17.7.2.3.5. Elemental analysis techniques

17.7.2.3.6. Others

17.7.2.4. Argentina Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

17.7.2.4.1. Elemental Impurities

17.7.2.4.2. Volatile Organic Impurities

17.7.2.4.3. Extractables and Leachables

17.7.2.4.4. Semi-Volatile Organic Impurites

17.7.2.4.5. Non-Volatile Organic Impurites

17.7.2.4.6. Counterion Analysis

17.7.2.4.7. Others

17.7.2.5. Argentina Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

17.7.2.5.1. Pharmaceutical Microbiology

17.7.2.5.1.1. Sterility Testing

17.7.2.5.1.2. Antimicrobial Efficacy Testing (AET)

17.7.2.5.1.3. Microbial Limits Testing

17.7.2.5.1.4. Bioburden Determination

17.7.2.5.1.5. Endotoxin Testing

17.7.2.5.1.6. Environmental Monitoring and Identification

17.7.2.5.1.7. Packaging Testing

17.7.2.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

17.7.2.5.1.9. Pharmaceutical Gas Testing

17.7.2.5.1.10. Viral Safety Testing and Lot Release Testing

17.7.2.5.1.11. Others (Water Analysis and etc.)

17.7.2.5.2. Pharmaceutical Chemistry

17.7.2.5.2.1. Elemental Impurities

17.7.2.5.2.2. Volatile Organic Impurities

17.7.2.5.2.3. Extractables and Leachables

17.7.2.5.2.4. Semi-Volatile Organic Impurites

17.7.2.5.2.5. Non-Volatile Organic Impurites

17.7.2.5.2.6. Counterion Analysis

17.7.2.5.2.7. Others

17.7.3. Rest of Latin America

17.7.3.1. Rest of Latin America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Application

17.7.3.1.1. Allergens, antigens, vaccines and hormones

17.7.3.1.2. Cytokines, enzymes and human whole-blood

17.7.3.1.3. Plasma derivative

17.7.3.1.4. Immune sera, immunoglobulins and products of fermentation

17.7.3.1.5. Others (diagnostic agents for in vitro use, etc.)

17.7.3.2. Rest of Latin America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Offering

17.7.3.2.1. Consumables and Instruments

17.7.3.2.2. Solution

17.7.3.2.3. Services

17.7.3.3. Rest of Latin America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By  Techniques

17.7.3.3.1. GC/MS

17.7.3.3.2.  LC/MS/ High Performance Liquid (HPLC)

17.7.3.3.3. Ultra High Performance Liquid (UHPLC)

17.7.3.3.4. Supercritical Fluid (SFC) chromatography

17.7.3.3.5. Elemental analysis techniques

17.7.3.3.6. Others

17.7.3.4. Rest of Latin America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Testing Categories

17.7.3.4.1. Elemental Impurities

17.7.3.4.2. Volatile Organic Impurities

17.7.3.4.3. Extractables and Leachables

17.7.3.4.4. Semi-Volatile Organic Impurites

17.7.3.4.5. Non-Volatile Organic Impurites

17.7.3.4.6. Counterion Analysis

17.7.3.4.7. Others

17.7.3.5. Rest of Latin America Pharmaceutical Quality Control Market Revenue (US$ Mn) and Forecasts, By Analysis Type

17.7.3.5.1. Pharmaceutical Microbiology

17.7.3.5.1.1. Sterility Testing

17.7.3.5.1.2. Antimicrobial Efficacy Testing (AET)

17.7.3.5.1.3. Microbial Limits Testing

17.7.3.5.1.4. Bioburden Determination

17.7.3.5.1.5. Endotoxin Testing

17.7.3.5.1.6. Environmental Monitoring and Identification

17.7.3.5.1.7. Packaging Testing

17.7.3.5.1.8. Pharmaceutical and Biopharmaceutical  Release Testing

17.7.3.5.1.9. Pharmaceutical Gas Testing

17.7.3.5.1.10. Viral Safety Testing and Lot Release Testing

17.7.3.5.1.11. Others (Water Analysis and etc.)

17.7.3.5.2. Pharmaceutical Chemistry

17.7.3.5.2.1. Elemental Impurities

17.7.3.5.2.2. Volatile Organic Impurities

17.7.3.5.2.3. Extractables and Leachables

17.7.3.5.2.4. Semi-Volatile Organic Impurites

17.7.3.5.2.5. Non-Volatile Organic Impurites

17.7.3.5.2.6. Counterion Analysis

17.7.3.5.2.7. Others

17.8. Key Segment for Channeling Investments

17.8.1. By Country

17.8.2. By Application

17.8.3. By Offering

17.8.4. By  Techniques

17.8.5. By Testing Categories

17.8.6. By Analysis Type

18. Competitive Benchmarking

18.1. Market Share Analysis, 2020

18.2. Global Presence and Growth Strategies

18.2.1. Mergers and Acquisitions

18.2.2. Product Launches

18.2.3. Investments Trends

18.2.4. R&D Initiatives

19. Player Profiles

19.1. Lucideon Limited

19.1.1. Company Details

19.1.2. Company Overview

19.1.3. Product Offerings

19.1.4. Key Developments

19.1.5. Financial Analysis

19.1.6. SWOT Analysis

19.1.7. Business Strategies

19.2. ThermoFisher Scientific 

19.2.1. Company Details

19.2.2. Company Overview

19.2.3. Product Offerings

19.2.4. Key Developments

19.2.5. Financial Analysis

19.2.6. SWOT Analysis

19.2.7. Business Strategies

19.3. Merck KGaA

19.3.1. Company Details

19.3.2. Company Overview

19.3.3. Product Offerings

19.3.4. Key Developments

19.3.5. Financial Analysis

19.3.6. SWOT Analysis

19.3.7. Business Strategies

19.4. Charles River Laboratories

19.4.1. Company Details

19.4.2. Company Overview

19.4.3. Product Offerings

19.4.4. Key Developments

19.4.5. Financial Analysis

19.4.6. SWOT Analysis

19.4.7. Business Strategies

19.5. Eurofins Scientific

19.5.1. Company Details

19.5.2. Company Overview

19.5.3. Product Offerings

19.5.4. Key Developments

19.5.5. Financial Analysis

19.5.6. SWOT Analysis

19.5.7. Business Strategies

19.6. SGS Group Management SA

19.6.1. Company Details

19.6.2. Company Overview

19.6.3. Product Offerings

19.6.4. Key Developments

19.6.5. Financial Analysis

19.6.6. SWOT Analysis

19.6.7. Business Strategies

19.7. Toxikon Corporation

19.7.1. Company Details

19.7.2. Company Overview

19.7.3. Product Offerings

19.7.4. Key Developments

19.7.5. Financial Analysis

19.7.6. SWOT Analysis

19.7.7. Business Strategies

19.8.  Sartorius AG

19.8.1. Company Details

19.8.2. Company Overview

19.8.3. Product Offerings

19.8.4. Key Developments

19.8.5. Financial Analysis

19.8.6. SWOT Analysis

19.8.7. Business Strategies

19.9. Other Market Participants

20. Key Findings

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews  are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.  

Prominent participants in our primary research process include:

  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers

Research Methodology

Methodology

Key Inclusions

Methodology

Request A Sample

Ask for Discount

Enquiry Before Buying

Request For Customization

Purchase Options

Buy Now

Reach to us

Call us on

+91-74002-42424

Drop us an email at

sales@absolutemarketsinsights.com